Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive

专利摘要:

公开号:AU2008284217A1
申请号:U2008284217
申请日:2008-03-27
公开日:2009-02-12
发明作者:Craig A. Bonda；Anna Pavlovic
申请人:Hallstar Innovations Corp；
IPC主号:A61K8-40

专利说明:
WO 2009/020676 PCT/US2008/058458 METHOD OF QUENCHING ELECTRONIC EXCITATION OF CHROMOPHORE CONTAINING ORGANIC MOLECULES IN PHOTOACTIVE COMPOSITIONS FIELD OF THE INVENTION [00011 The present invention is directed to a method of quenching electronic excited state(s) of chromophore-containing UV-absorbing organic molecules in photoactive compositions. More particularly, it has been found that a-cyano-p,p diphenylacrylates (crylenes) having an alkoxy radical, preferably on one of the phenyl rings (alternatively on both phenyl rings), quenches the excited state of the chromophore by accepting the excited state energy (singlet and sometimes also the triplet state), thereby returning the UV-absorbing molecule back to its ground state so that the chromophore can absorb more photons, e.g., from ultraviolet (UV) light, thereby photostabilizing UV-absorbing chromophore-containing organic molecules, particularly butyl methoxydibenzoylmethane (Avobenzone), octyl methoxycinnamate (Octinoxate), and octyl salicylate (Octisalate) in photoactive compositions. BACKGROUND [0002] The absorption of ultraviolet light by a chromophore-containing organic molecule causes the excitation of an electron in the chromophore moiety from an initially occupied, low energy orbital to a higher energy, previously unoccupied orbital. The energy of the absorbed photon is used to energize an electron and cause it to "jump" to a higher energy orbital, see Turro, Modern Molecular Photochemistry, 1991. Two excited electronic states derive from the electronic orbital configuration produced by UV light absorption. In one state, the electron spins are paired (antiparallel) and in the other state the electron spins are unpaired (parallel). The state with paired spins has no resultant spin magnetic moment, but the state with unpaired spins possesses a net spin magnetic moment. A state with paired spins remains a single state in the presence of a magnetic field, and is termed a singlet state. A state with unpaired spins interacts with a magnetic field and splits into three quantized states, and is termed a triplet state. [0003] In the electronically excited state, the chromophore-containing organic molecule is prone to degrade via a number of known pathways and, therefore, can absorb little or no additional UV light. To photostabilize an electronically excited chromophore-containing organic molecule in order to provide sufficient UV protection, it must be returned to the ground state before it undergoes a photochemical reaction destructive to its UV absorbing - 1 - WO 2009/020676 PCT/US2008/058458 capability. There are known photostabilizing sunscreen additives, such as Octocrylene, methylbenzilydene camphor, and the esters or polyesters of naphthalene dicarboxylic acid of this assignee's U.S. Patent Nos. 6,113,931; 6,284,916; 6,518,451; and 6,551,605, all hereby incorporated by reference, that are capable of quenching excited triplet state energy. Surprisingly, it has been found that alkoxy crylenes, particularly methoxy crylenes, return chromophore-containing organic molecules, particularly butyl methoxydibenzoylmethane (Avobenzone), octyl methoxycinnamate (Octinoxate), and octyl salicylate (Octisalate), from both an electronically excited singlet state and excited triplet state back to their ground state, thereby photostabilizing the UV-absorbing organic molecules. [0004] Deflandre U.S. 5,576,354 generally discloses a cosmetic sunscreen composition containing at least 1% by weight of an a-cyano-p, p-diphenylacrylate that will photostabilize a dibenzoylmethane derivative, e.g., Parsol 1789 (Avobenzone), so long as the composition contains a fatty phase, e.g., glycerol stearates, isopropyl myristate or the like, and so long as the mole ratio of the a-cyano-p, P-diphenylacrylate to the dibenzoylmethane derivative is at least 0.8. The compounds preferred in the '354 patent and disclosed in the examples are octocrylene, which contains no alkoxy radical(s) (UVINULN 539); P, p-bis (4 methoxyphenyl) acrylates (containing no cyano radical); and the U-cyano-p, p diphenylacrylates, which contain no alkoxy radical(s). [00051 As stated in this assignees pending applications, Serial Nos. 10/241,388; 10/361,223; and 10/7865,793, an a-cyano-pp-diphenylacrylate compound (e.g., octocrylene) is known to quench (accept) the excited triplet state energy of an excited photoactive compound by dissipating the energy kinetically in the form of rapid isomerizations. This process is shown below: 0 N 0 N 0 0 Energy A A wherein the a-cyano-P,P-diphenylacrylate compound (octocrylene shown above as structure A), accepts the triplet excited state energy from a photoactive compound and forms -2- WO 2009/020676 PCT/US2008/058458 a diradical (shown above as structure A) at the cc and P positions of the acrylate, which converts the double bond into a single bond and allows for the free rotation of the phenyl groups. This rotation occurs rapidly and efficiently to dissipate any excited triplet state energy accepted by the a-cyano-Pp-diphenylacrylate compound from the photoactive compound. [0006] While octocrylene is able to quench (accept) the triplet excited state energy from a photoactive compound, thereby photostabilizing, to some degree, dibenzoylmethane derivatives, as shown in examples 1, 4, 6 and 8 of Deflandre et al. U.S. Patent No. 5,576,354, hereby incorporated by reference, there exists a need in the photoactive composition art to find one or more compounds that quench (accept) the singlet excited state energy and preferably also the triplet excited state energy from photoactive compounds, which octocrylene does not. [00071 Quite surprisingly, it has been found that the alkoxy substituted a-cyano-p, p diphenylacrylates (alkoxy crylenes) will quench the electronically excited singlet state energy of UV-absorbing organic molecules, such as the dibenzoylmethane derivatives of U.S. Patent No. 5,576,354, even at very low loadings compared to the quantity of UV-absorbing compounds. SUMMARY [0008] The photostabilizing electronic excited state energy - particularly singlet state energy from a UV-absorbing molecule - has been found to be readily transferred to (accepted by) c-cyanodiphenylacrylate compounds having an alkoxy radical in the four (para) position (hereinafter "alkoxycrylenes") on one or both of the phenyl rings having the formula (I): /R COOF 3 (I) C=C F2 - : / C=N wherein one or both of Ri and R 2 is a straight or branched chain C-C 30 alkoxy radical, preferably C-C 8 , more preferably methoxy, and any non-alkoxy radical Ri or R 2 is hydrogen; and R 3 is a straight or branched chain CI-C 30 alkyl radical, preferably C 2
-C
20 . -3- WO 2009/020676 PCT/US2008/058458 BRIEF DESCRIPTION OF THE DRAWINGS [00091 Fig. 1 is a graph showing the photostability of the sunscreen compositions of Examples 1-3 (when irradiated with 35 MED of UV radiation) provided by 4.5% octyldocedyl methoxy crylene (C2OMC); and 2.75% Octocrylene (OC) compared to the photostability prior to UV irradiation and compared to the composition with no photostabilizer; [00101 Fig. 2 is a graph showing the photostability of the sunscreen composition of Example 4 before and after irradiation with 35 MED of UV radiation; [0011] Fig. 3 is a graph showing the photostability of the sunscreen composition of Example 5 before and after irradiation with 35 MED of UV radiation; and [0012] Fig. 4 is a graph showing the photostability of the sunscreen composition of Example 6 before and after irradiation with 35 MED of UV radiation; and [0013] Fig. 5 is a graph showing the sunscreen composition of Example 7 before and after irradiation with 35 MED of UV radiation. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS [0014] Ranges may be expressed herein as from "about" or "approximately" one particular value and/or to "about" or "approximately" another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about," it will be understood that the particular value forms another embodiment. [0015] The term "alkoxy" herein refers to a radical extending from the para position of one or both of the phenyl rings having the formula O-R, wherein R is an alkyl radical, straight chain or branched having 1 to 30 carbon atoms, preferably wherein R=C 1 to C 8 , more preferably CrC 20 , and most preferably -O-CH 3 (methoxy). The oxygen atom of the alkoxy radical is covalently bonded to the para carbon atom of one or both of the phenyl rings, preferably only one of the phenyls, preferably having the formula (II) or (III): -4- WO 2009/020676 PCT/US2008/058458
CH
3 -0 COOR 3 c~c (II) C=N , or
COOR
3
CH
3 -0 /C N wherein R 3 is as previously defined. [0016] The term "crylene" as used herein refers to a chromophoric moiety that includes an a-cyano-pp-diphenyl propanoic acid ester. [0017] The term "cyano" as used herein refers to a -C=N group, also designated "-CN." [0018] Photoactive compositions, e.g., sunscreen compositions, generally include UV-A and UV-B photoactive compounds in a cosmetically acceptable carrier, optionally including additives, such as emollients, stabilizers, emulsifiers, and combinations thereof. These additives can be used in preparing a UV filter composition in an emulsion (oil-in-water or water-in-oil) from a composition that includes one or more photoactive compounds and a solvent or a solvent combination that includes one or more organic solvents and water. When made, preferably the emulsion is an oil-in-water emulsion, wherein the oil phase is primarily formed from a mixture of the UV filter compound(s) and one or more organic solvents. [0019] A typical photoactive composition includes one or more photoactive compounds, wherein the photoactive compound(s) act to absorb UV radiation and thereby protect the substrate (e.g., human skin, resins, films, and the like) from the harmful effects of UV radiation. The absorption process causes a photoactive compound to reach an excited state, wherein the excited state is characterized by the presence of excited electronic energy (e.g., singlet state energy or triplet state energy), as compared to the ground state of the photoactive compound. Once a photoactive compound reaches an excited state there exists a number of pathways by which the excited photoactive compound can dissipate its excess energy (e.g., singlet and/or triplet energy), however, many of those pathways adversely affect the ability of -5- WO 2009/020676 PCT/US2008/058458 the photoactive compound to further absorb UV radiation. The alkoxy crylene molecules described herein accept electronic singlet excited state energy from UV-absorbers, particularly Avobenzone, octyl methoxycinnamate (Octinoxate), and octyl salicylate (Octisalate). The alkoxy crylenes also are very effective UVA absorbers in addition to providing electronic singlet state energy quenching of other UV-absorbing compounds in sunscreen compositions. The alkoxy crylene molecules described herein are especially effective when combined with one or more additional electronic singlet excited state quenching compounds such as oxybenzone. Particularly surprising photostabilization is achieved in sunscreen compositions containing the alkoxy crylene molecules described herein together with octyl methoxycinnamate and Avobenzone. [0020] A photoactive compound is one that responds to light photoelectrically. In the compositions and methods of photostabilization disclosed herein, a photoactive compound is one that responds to UV radiation photoelectrically. For example, all photoactive compound containing compositions that respond to UV radiation photoelectrically by photoactive compound photodegradation benefit highly by the inclusion of the alkoxy crylene molecules described herein. The alkoxy crylenes described herein are useful photostabilizers and/or photoactive compounds when combined with any single or combination photoactive compounds identified in Shaath, Nadim, Encyclopedia of UV filters, @ 2007, hereby incorporated by reference. Photostability is a problem with all UV filters because they all reach an electronic singlet excited state upon exposure to UV radiation. [0021] It is theorized that the following UV filters are photostabilized by the alkoxy crylene molecules described herein, including all of the following, including combinations of any two or more, and include compounds selected from the following categories (with specific examples) including: p-aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic acid); anthranilates (o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters); salicylates (octyl, amyl, phenyl, benzyl, menthyl (homosalate), glyceryl, and dipropyleneglycol esters); cinnamic acid derivatives (menthyl and benzyl esters, alpha-phenyl cinnamonitrile; butyl cinnamoyl pyruvate); dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone, methylaceto-umbelliferone); camphor derivatives (3 benzylidene, 4 methylbenzylidene, polyacrylamidomethyl benzylidene, benzalkonium methosulfate, benzylidene camphor sulfonic acid, and terephthalylidene dicamphor sulfonic acid); -6- WO 2009/020676 PCT/US2008/058458 trihydroxycinnamic acid derivatives (esculetin, methylesculetin, daphnetin, and the glucosides, esculin and daphnin); hydrocarbons (diphenylbutadiene, stilbene); dibenzalacetone; benzalacetophenone; naphtholsulfonates (sodium salts of 2-naphthol-3,6 disulfonic and of 2-naphthol-6,8-disulfonic acids); dihydroxy-naphthoic acid and its salts; o and p-hydroxydiphenyldisulfonates; coumarin derivatives (7-hydroxy, 7-methyl, 3-phenyl); diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole, methyl naphthoxazole, various aryl benzothiazoles); quinine salts (bisulfate, sulfate, chloride, oleate, and tannate); quinoline derivatives (8-hydroxyquinoline salts, 2-phenylquinoline); hydroxy- or methoxy-substituted benzophenones; uric acid derivatives; vilouric acid derivatives; tannic acid and its derivatives; hydroquinone; and benzophenones (oxybenzone, sulisobenzone, dioxybenzone, benzoresorcinol, octabenzone, 4-isopropyldibenzoylmethane, butylmethoxydibenzoylmethane, etocrylene, and 4-isopropyl-dibenzoylmethane). [0022] The following UV filters should be particularly photostabilized by the alkoxy crylene molecules described herein: 2-ethylhexyl p-methoxycinnamate, 4,4'-t-butyl methoxydibenzoylmethane, octyldimethyl p-aminobenzoate, digalloyltrioleate, ethyl 4 [bis(hydroxypropyl)laminobenzoate, 2-ethylhexylsalicylate, glycerol p-aminobenzoate, 3,3,5 trimethylcyclohexylsalicylate, and combinations thereof. [0023] Photoactive compositions disclosed herein can include a variety of photoactive compounds, preferably including one or more UV-A photoactive compounds and one or more UV-B photoactive compounds. Preferably, a sunscreen composition includes a photoactive compound selected from the group consisting of p-aminobenzoic acid and salts and derivatives thereof; anthranilate and derivatives thereof; dibenzoylmethane and derivatives thereof; salicylate and derivatives thereof; cinnamic acid and derivatives thereof; dihydroxycinnamic acid and derivatives thereof; camphor and salts and derivatives thereof; trihydroxycinnamic acid and derivatives thereof; dibenzalacetone naphtholsulfonate and salts and derivatives thereof; benzalacetophenone naphtholsulfonate and salts and derivatives thereof; dihydroxy-naphthoic acid and salts thereof; o-hydroxydiphenyldisulfonate and salts and derivatives thereof; p-hydroxydiphenyldisulfonate and salts and derivatives thereof; coumarin and derivatives thereof; diazole derivatives; quinine derivatives and salts thereof; quinoline derivatives; uric acid derivatives; vilouric acid derivatives; tannic acid and derivatives thereof; hydroquinone; diethylamino hydroxybenzoyl hexyl benzoate and salts and derivatives thereof; and combinations of the foregoing. -7- WO 2009/020676 PCT/US2008/058458 [0024] UV A radiation (about 320 nm to about 400 nm), is recognized as contributing to causing damage to skin, particularly to very lightly colored or sensitive skin. A sunscreen composition disclosed herein preferably includes a UV-A photoactive compound. Preferably, a sunscreen composition disclosed herein includes a dibenzoylmethane derivative UV-A photoactive compound. Preferred dibenzoylmethane derivatives include, 2 methyldibenzoylmethane; 4-methyldibenzoylmethane; 4-isopropyldibenzoylmethane; 4-tert butyldibenzoylmethane; 2,4-dimethyldibenzoylmethane; 2,5-dimethyldibenzoylmethane; 4,4'-diisopropyldibenzoylmethane; 4,4'-dimethoxydibenzoylmethane; 4-tert-butyl-4' methoxydibenzoylmethane; 2-methyl-5-isopropyl-4'-methoxydibenzoylmethane; 2-methyl-5 tert-butyl-4'-methoxydibenzoylmethane; 2,4-dimethyl-4'-methoxydibenzoylmethane; 2,6 dimethyl-4-tert-butyl-4'-methoxydibenzoylmethane, and combinations thereof. [0025] For a product marketed in the United States, preferred cosmetically acceptable photoactive compounds and concentrations (reported as a percentage by weight of the total cosmetic sunscreen composition) include: aminobenzoic acid (also called para aminobenzoic acid and PABA; 15% or less), Avobenzone (also called butyl methoxy dibenzoylmethane; 3% or less), cinoxate (also called 2 ethoxyethyl p methoxycinnamate; 3% or less), dioxybenzone (also called benzophenone 8; 3% or less), homosalate ((also called 3,3,5 trimethylcyclohexyl salicylate, 15% or less), , menthyl anthranilate (also called menthyl 2 aminobenzoate; 5% or less), octocrylene (also called 2 ethylhexyl 2 cyano 3,3 diphenylacrylate; 10% or less), octyl methoxycinnamate (7.5% or less), octyl salicylate (also called 2 ethylhexyl salicylate; 5% or less), oxybenzone (also called benzophenone 3; 6% or less), padimate 0 (also called octyl dimethyl PABA; 8% or less), phenylbenzimidazole sulfonic acid (water soluble; 4% or less), sulisobenzone (also called benzophenone 4; 10% or less), titanium dioxide (25% or less), trolamine salicylate (also called triethanolamine salicylate; 12% or less), and zinc oxide (25% or less). [0026] Other preferred cosmetically acceptable photoactive compounds and preferred concentrations (percent by weight of the total cosmetic sunscreen composition) include diethanolamine methoxycinnamate (10% or less), ethyl-[bis(hydroxypropyl)] aminobenzoate (5% or less), glyceryl aminobenzoate (3% or less), 4 isopropyl dibenzoylmethane (5% or less), 4 methylbenzylidene camphor (6% or less), terephthalylidene dicamphor sulfonic acid (10% or less), and sulisobenzone (also called benzophenone 4, 10% or less). -8- WO 2009/020676 PCT/US2008/058458 [00271 For a product marketed in the European Union, preferred cosmetically acceptable photoactive compounds and preferred concentrations (reported as a percentage by weight of the total cosmetic sunscreen composition) include: PABA (5% or less), camphor benzalkonium methosulfate (6% or less), homosalate (10% or less), benzophenone 3 (10% or less), phenylbenzimidazole sulfonic acid (8% or less, expressed as acid), terephthalidene dicamphor sulfonic acid (10% or less, expressed as acid), butyl methoxydibenzoylmethane (5% or less), benzylidene camphor sulfonic acid (6% or less, expressed as acid), octocrylene (10% or less, expressed as acid), polyacrylamidomethyl benzylidene camphor (6% or less), ethylhexyl methoxycinnamate (10% or less), PEG 25 PABA (10% or less), isoamyl p methoxycinnamate (10% or less), ethylhexyl triazone (5% or less), drometrizole trielloxane (15% or less), diethylhexyl butamido triazone (10% or less), 4 methylbenzylidene camphor (4% or less), 3 benzylidene camphor (2% or less), ethylhexyl salicylate (5% or less), ethylhexyl dimethyl PABA (8% or less), benzophenone 4 (5%, expressed as acid), methylene bis benztriazolyl tetramethylbutylphenol (10% or less), disodium phenyl dibenzimidazole tetrasulfonate (10% or less, expressed as acid), bis ethylhexyloxyphenol methoxyphenol triazine (10% or less), methylene bisbenzotriazolyl tetramethylbutylphenol (10% or less, also called TINOSORB M or Bisoctrizole), and bisethylhexyloxyphenol methoxyphenyl triazine.(10% or less, also called TINOSORB S or Bemotrizinol). [0028] All of the above described UV filters are commercially available. For example, suitable commercially available organic UV filters are identified by trade name and supplier in Table I below: -9- WO 2009/020676 PCT/US2008/058458 TABLE I CTFA Name Trade Name Supplier benzophenone-3 UVINUL M-40 BASF Chemical Co. benzophenone-4 UVINUL MS-40 BASF Chemical Co. benzophenone-8 SPECTRA-SORB UV-24 American Cyanamid DEA-methoxycinnamate BERNEL HYDRO Bernel Chemical diethylamino hydroxybenzoyl hexyl UVINUL A-PLUS BASF Chemical Co. benzoate diethylhexyl butamido triazone UVISORB HEB 3V-Sigma disodium phenyl dibenzylimidazole NEO HELIOPAN AP Symrise ethyl dihydroxypropyl-PABA AMERSCREEN P Amerchol Corp. glyceryl PABA NIPA G.M.P.A. Nipa Labs. homosalate KEMESTER HMS Humko Chemical menthyl anthranilate SUNAROME UVA Felton Worldwide octocrylene UVINUL N-539 BASF Chemical Co. octyl dimethyl PABA AMERSCOL Amerchol Corp. octyl methoxycinnamate PARSOL MCX Bernel Chemical PABA PABA National Starch -phenylbenzimidazole-5- EUSOLEX 6300 EM Industries sulphonic acid TEA salicylate SUNAROME W Felton Worldwide 2-(4-methylbenzildene)-camphor EUSOLEX 6300 EM Industries benzophenone-1 UVINUL 400 BASF Chemical Co. benzophenone-2 UVINUL D-50 BASF Chemical Co. benzophenone-6 UVINUL D-49 BASF Chemical Co. benzophenone- 12 UVINUL 408 BASF Chemical Co. 4-isopropyl dibenzoyl methane EUSOLEX 8020 EM Industries butyl methoxy dibenzoyl methane PARSOL 1789 'ivaudan Corp. etocrylene UVINUL N-35 BASF Chemical Co. methylene bisbenzotriazolyl TINOSORB M Ciba Specialty tetramethylbutylphenol Chemicals bisethylhexyloxyphenol TINOSORB S Ciba Specialty methoxyphenyl triazine. Chemicals [0029] Commonly-assigned U.S. Patent Nos. 6,485,713 and 6,537,529, the disclosures of which are hereby incorporated herein by reference, describe compositions and methods for increasing the photostability of photoactive compounds in a sunscreen composition, e.g., by the addition of polar solvents to the oil phase of a composition. By increasing the polarity of the oil phase of a sunscreen composition including the alkoxy crylenes described herein, e.g., methoxy crylene, the stability of the sunscreen composition is surprisingly increased in comparison to octocrylene. In the sunscreen compositions described herein, preferably, one or more of a highly polar solvent is present in the oil-phase of the composition. Preferably, a sufficient amount of a polar solvent is present in the sunscreen composition to raise the - 10 - WO 2009/020676 PCT/US2008/058458 dielectric constant of the oil-phase of the composition to a dielectric constant of at least about 7, preferably at least about 8. With or without the highly polar solvent in the oil phase, the methoxy crylene molecules described herein yield unexpected photostability in comparison to octocrylene. [0030] A photoactive compound can be considered stable when, for example, after 30 MED irradiation the photoactive compound has retained at least about 90% of its original absorbance at a wavelength, or over a range of wavelengths of interest (e.g., the wavelength at which a photoactive compound has a peak absorbance, such as 350-370 nm for Avobenzone). Likewise, a sunscreen composition can include a plurality of photoactive compounds and a sunscreen composition, as a whole, can be considered stable when, for example, after 30 MED irradiation the sunscreen composition has retained at least about 90% of its original absorbance at one or more wavelengths of interest (e.g., at or near the peak absorbance wavelength of the primary photoactive compound). [0031] In accordance with one important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with a water soluble UV filter compound and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative and/or a dialkyl naphthalate. [0032] Advantageous water-soluble UV filter substances for the purposes of the present invention are sulfonated UV filters, in particular: phenylene-1,4-bis(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid, which has the following structure: SOJH SOIdH NN HO3S i so and its salts, especially the corresponding sodium, potassium or triethanolammonium salts, in particular phenylene-1,4-bis(2-benzimidazyl)- -3,3'-5,5'-tetrasulfonic acid bissodium salt - 11 - WO 2009/020676 PCT/US2008/058458 N N NaOIS Nil NHi3 3~SOINa with the INCI name disodium phenyl dibenzimidazole tetrasulfonate (CAS No.: 180898-37-7), which is obtainable for example under the proprietary name Neo Heliopan A P from Haarmann & Reimer. [0033] Further advantageous sulfonated UV filters for the purposes of the present invention are the salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or its triethanolammonium salts, and the sulfonic acid itself N SNH NR [0034] with the INCI name phenylbenzimidazole sulfonic acid (CAS No. 27503-81-7), which is obtainable for example under the proprietary name Eusolex 232 from Merck or under Neo Heliopan Hydro from Haarmann & Reimer. [0035] Further advantageous water-soluble UV-B and/or broad-band filter substances for the purposes of the present invention are, for example, sulfonic acid derivatives of 3 benzylidenecamphor, such as, for example, 4
-(
2 -oxo-3-bomylidenemethyl)benzene-sulfonic acid, 2-methyl-5-(2-oxo-3-bomylidenemethyl)sulfonic acid and the salts thereof. [00361 The total amount of one or more water-soluble UV filter substances in the finished cosmetic or dermatological preparations is advantageously chosen from the range 0.01% by weight to 20% by weight, preferably from 0.1 to 10% by weight, in each case based on the total weight of the preparations. [00371 In accordance with another important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with a hydroxybenzophenone - 12 - WO 2009/020676 PCT/US2008/058458 compound and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative and/or a dialkyl naphthalate. [0038] With an alkoxycrylene, it is possible to completely dispense with the use of other UV stabilizers, in particular the use of ethylhexyl-2-cyano-3,3-diphenylacrylate(octocrylene) or 4-methylbenzylidenecamphor. [0039] Hydroxybenzophenones are characterized by the following structural formula: where R ' and R 2 independent of one another are hydrogen, C C 2 o-alkyl, C 3 -Cio-cycloalkyl or
C
3 -Cio-cyloalkenyl, wherein the substituents R' and R2 together with the nitrogen atom to which they are bound can form a 5- or 6-ring and R 3 is a CI-C 2 0 alkyl radical. [0040] A particularly advantageous hydroxybenzophenone is the 2-(4'-diethylamino-2' hydroxybenzoyl)benzoic acid hexyl ester (also: aminobenzophenone) which is characterized by the following structure: and is available from BASF under the Uvinul A Plus. [0041] According to the invention, cosmetic or dermatological preparations contain 0.1 to 20% by weight, advantageously 0.1 to 15% by weight, very particularly preferred 0.1 to 10% by weight, of one or more hydroxybenzophenones. - 13 - WO 2009/020676 PCT/US2008/058458 [0042] Within the scope of the present invention, dialkyl naphthalates for which R' and/or represent branched alkyl groups with 6 to 10 carbon atoms are advantageous. Within the scope of the present invention diethylhexyl naphthalate is very particularly preferred which is available, e.g., under the trade name Hallbrite TQTM from CP Hall or Corapan TQTM from H&R. [0043] According to one embodiment of the invention cosmetic or dermatological preparations advantageously contain 0.001 to 30% by weight, preferably 0.01 to 20% by weight, very particularly preferred 0.5 to 15% by weight, of one or more dialkyl naphthalates. [0044] The cosmetic or dermatological light-protection formulations according to the invention can be composed as usual and be used for cosmetic or dermatological light protection, furthermore for the treatment, care and cleansing of the skin and/or hair and as a cosmetic product in decorative cosmetics. [0045] In accordance with another important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with a benzotriazole derivatives compound and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative and/or a dialkyl naphthalate. [00461 An advantageous benzotriazole derivative is 2,2'-methylenebis(6-(2H-benzotriazol 2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol), which has the chemical structural formula N)N [0047] (INCl: bisoctyltriazole). It is obtainable under the proprietary name Tinosorb* from CIBA-Chemikalien GmbH and is distinguished by good UV absorption properties. The disadvantage of this substance is the characteristic of forming imperceptibly thin films on the skin which have unpleasant tactile properties. - 14 - WO 2009/020676 PCT/US2008/058458 [00481 Another disadvantage is that such benzotriazole derivatives show only inadequate solubility, if any, in conventional oil components. Well-known solvents can dissolve only up to a maximum of 15% by weight of these compounds, which usually corresponds to a concentration of about I to 1.5% by weight of dissolved (=active) filter substance in the complete cosmetic or dermatological preparation. [0049] One disadvantage of the prior art is accordingly that generally only comparatively low sun protection factors have been achievable with these filter substances because their solubility or dispersibility in the formulations is too low, i.e. they can be satisfactorily incorporated into such formulations only with difficulty or not at all. [0050] Even if it is also possible in principle to achieve a certain UV protection when the solubility is limited, another problem frequently occurs, that is recrystallization. [0051] Substances of low solubility in particular recrystallize comparatively rapidly, which may be induced by fluctuations in temperature or other influences. Uncontrolled recrystallization of an essential ingredient of a preparation such as a UV filter has, however, extremely disadvantageous effects on the properties of the given preparation and, not least, on the desired light protection. [0052] In accordance with another embodiment, the alkoxycrylene-containing compositions described herein can contain an increased content of unsymmetrically substituted triazine derivatives when combined together with an alkoxycrylene of formula (I) to obtain an increased sun protection factor. [0053] It was, however, surprising and not predictable for the skilled worker that the disadvantages of the prior art are remedied by active ingredient combinations effective for light protection and composed of (a) one or more UV filter substances selected from the group of benzotriazole derivatives; (b) an alkoxycrylene of formula (I); and optionally (c) one or more dialkyl naphthalates having the structural formula: - 15 - WO 2009/020676 PCT/US2008/058458 W in which R ' and R 2 are, independently of one another, selected from the group of branched and unbranched alkyl groups having 6 to 24 carbon atoms. [0054] Particularly advantageous light protection filters for the purpose of this embodiment of the present invention include a benzotriazole compound having a structural formula: N ' N COR N where R, and R 2 are, independently of one another, selected from the group of branched or unbranched CI -Ci 8 -alkyl radicals, of C 5 -C1 2 -cycloalkyl or aryl radicals which are optionally substituted by one or more C 1
-C
4 alkyl groups. [0055] The preferred benzotriazole derivative is 2,2'-methylenebis(6-(2H-benzotriazol-2 yl)-4-(1,1,3,3-tetramethylbutyl)phenol) which is characterized by the chemical structural formula: )If (AI
N
[0056] An advantageous broadband filter for the purpose of the present invention is moreover 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(t - 16 - WO 2009/020676 PCT/US2008/058458 rimethyl-silyl)oxyIdisiloxanylIpropylIphenol (CAS No.: 155633-54-8) with the INCI name drometrizole trisiloxane, which is characterized by the chemical structural formula 7( O-Si(CH3) N HO [0057] The total amount of one or more benzotriazole derivatives, in particular of 2,2' methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phe nol) and/or 2-(2H benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(t rimethylsilyl)oxy]disiloxa-nylIpropyl ]phenol, in the finished cosmetic or dermatological preparations is advantageously chosen from the range from 0.1 to 15.0% by weight, preferably 0.5 to 10.0% by weight, based on the total weight of the preparations. [0058] The cosmetic or dermatological light protection formulations of the invention may have conventional compositions and be used for cosmetic or dermatological light protection and for the treatment, care and cleansing of skin and/or the hair and as a make-up product in decorative cosmetics. [0059] For use, the cosmetic and dermatological preparations are applied to the skin and/or the hair in a sufficient quantity in the manner customary for cosmetics. [0060] Cosmetic and dermatological preparations according to the invention can comprise cosmetic auxiliaries such as those conventionally used in such preparations, e.g. preservatives, bactericides, perfumes, antifoams, dyes, pigments which have a coloring effect, thickeners, moisturizers and/or humectants, fats, oils, waxes or other conventional constituents of a cosmetic or dermatological formulation, such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives. [0061] An additional content of antioxidants is generally preferred. According to the invention, favorable antioxidants which can be used are any antioxidants suitable or conventional for cosmetic and/or dermatological applications. - 17 - WO 2009/020676 PCT/US2008/058458 [0062] The antioxidants are particularly advantageously chosen from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (e.g. urocanic acid) and derivatives thereof, peptides such as D,L-camosine, D carnosine, L-carnosine and derivatives thereof (e.g. anserine), carotenoids, carotenes (e.g. .alpha.-carotene, .beta.-carotene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, lipoic acid and derivatives thereof (e.g. dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and the glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, .gamma.-linoleyl, cholesteryl and glyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (e.g. buthionine sulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerated doses (e.g. pmol to .mu.mol/kg), and also (metal) chelating agents (e.g. .alpha.-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), .alpha.-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof (e.g. .gamma.-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of gum benzoin, rutinic acid and derivatives thereof, .alpha.-glycosylrutin, ferulic acid, furfurylideneglucitol, carnosine, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiaretic acid, trihydroxybutyro phenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (e.g. ZnO, ZnSO4, selenium and derivatives thereof (e.g. selenomethionine), stilbenes and derivatives thereof (e.g. stilbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of said active ingredients which are suitable according to the invention. [0063] In accordance with another important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with hydrophilic skincare active ingredients and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative. - 18 - WO 2009/020676 PCT/US2008/058458 [0064] Advantageous hydrophilic active ingredients which (individually or in any combinations with one another) are stabilized by their use together with an alkoxycrylene according to the invention include those listed below: biotin ; carnitine and derivatives ; creatine and derivatives ; folic acid ; pyridoxine; niacinamide ; polyphenols (in particular flavonoids, very particularly alpha-glucosylrutin); ascorbic acid and derivatives ; Hamamelis ; Aloe Vera ; panthenol ; amino acids. [0065] Particularly advantageous hydrophilic active ingredients for the purposes of the present invention are also water-soluble antioxidants, such as, for example, vitamins. [0066] The amount of hydrophilic active ingredients (one or more compounds) in the preparations is preferably 0.0001 to 10% by weight, particularly preferably 0.001 to 5% by weight, based on the total weight of the preparation. [0067] Particularly advantageous preparations are also obtained when antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously comprise one or more antioxidants. Favorable, but nevertheless optional antioxidants which may be used are all antioxidants customary or suitable for cosmetic and/or dermatological applications. [0068] The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight of the preparation. [0069] If vitamin E and/or derivatives thereof are the antioxidant or antioxidants, it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. [0070] If vitamin A or vitamin A derivatives, or carotenes or derivatives thereof are the antioxidant or antioxidants, it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. - 19 - WO 2009/020676 PCT/US2008/058458 [0071] It is particularly advantageous when the cosmetic preparations according to the present invention comprise further cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin against oxidative stress. [0072] Advantageous further active ingredients are natural active ingredients and/or derivatives thereof, such as e.g. ubiquinones, retinoids, carotenoids, creatine, taurine and/or .beta.-alanine. [0073] Formulations according to the invention, which comprise e.g. known antiwrinkle active ingredients, such as flavone glycosides (in particular .alpha.-glycosylrutin), coenzyme Q10, vitamin E and/or derivatives and the like, are particularly advantageously suitable for the prophylaxis and treatment of cosmetic or dermatological changes in skin, as arise, for example, during skin aging (such as, for example, dryness, roughness and formation of dryness wrinkles, itching, reduced refatting (e.g. after washing), visible vascular dilations (teleangiectases, couperosis), flaccidity and formation of wrinkles and lines, local hyperpigmentation, hypopigmentation and abnormal pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like). In addition, they are advantageously suitable against the appearance of dry or rough skin. [0074] In accordance with still another important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with particulate UV filter substances and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative and/or a dialkyl naphthalate. [0075] Preferred particulate UV filter substances for the purposes of the present invention are inorganic pigments, especially metal oxides and/or other metal compounds which are slightly soluble or insoluble in water, especially oxides of titanium (TiO 2 ), zinc (ZnO), iron (e.g. Fe 2 0 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (e.g. MnO), aluminum (A1 2 0 3 ), cerium (e.g. Ce 2
O
3 ), mixed oxides of the corresponding metals, and mixtures of such oxides, and the sulfate of barium (BaSO4). [0076] Zinc oxides for the purposes of the present invention may also be used in the form of commercially available oily or aqueous predispersions. Zinc oxide particles and predispersions of zinc oxide particles which are suitable according to the invention are - 20 - WO 2009/020676 PCT/US2008/058458 distinguished by a primary particle size of <300 nm and can be obtained under the following proprietary names from the stated companies: Proprietary name Coating Manufacturer Z-Cote HP1 2% Dimethicone BASF Z-Cote / BASF ZnO NDM 5% Dimethicone H&R ZnO Neutral / H&R MZ-300 / Tayca Corporation MZ-500 / Tayca Corporation MZ-700 / Tayca Corporation MZ-303S 3% Methicone Tayca Corporation MZ-505S 5% Methicone Tayca Corporation MZ-707S 7% Methicone Tayca Corporation MZ-303M 3% Dimethicone Tayca Corporation MZ-505M 5% Dimethicone Tayca Corporation MZ-707M 7% Dimethicone Tayca Corporation Z-Sperse Ultra ZnO (>=56%)/Ethylhexyl Collaborative Hydroxystearate Benzoate/ Laboratories Dimethicone/ Cyclomethicone Samt-UFZO- ZnO (60%)/Cyclomethicone/ Miyoshi Kasei 450/D5 (60%) Dimethicone [0077] Particularly preferred zinc oxides for the purposes of the invention are Z-Cote HP1 and Z-Cote from BASF and zinc oxide NDM from Haarmann & Reimer. [0078] Titanium dioxide pigments of the invention may be in the form of both the rutile and anatase crystal modification and may for the purposes of the present invention advantageously be surface-treated ("coated"), the intention being for example to form or retain a hydrophilic, amphiphilic or hydrophobic character. This surface treatment may consist of providing the pigments by processes known per se with a thin hydrophilic and/or hydrophobic inorganic and/or organic layer. The various surface coatings may for the purposes of the present invention also contain water. [0079] Inorganic surface coatings for the purposes of the present invention may consist of aluminum oxide (Al.sub.20.sub.3), aluminum hydroxide Al(OH).sub.3 or aluminum oxide hydrate (also: alumina, CAS No.: 1333-84-2), sodium hexametaphosphate - 21 - WO 2009/020676 PCT/US2008/058458 (NaPO.sub.3).sub.6, sodium metaphosphate (NaPO.sub.3).sub.n, silicon dioxide (SiO.sub.2) (also: silica, CAS No.: 7631-86-9), or iron oxide (Fe.sub.20.sub.3). These inorganic surface coatings may occur alone, in combination and/or in combination with organic coating materials. [00801 Organic surface coatings for the purposes of the present invention may consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicones), methylpolysiloxane (methicones), simethicones (a mixture of dimethylpolysiloxane with an average chain length of from 200 to 350 dimethylsiloxane units and silica gel) or alginic acid. These organic surface coatings may occur alone, in combination and/or in combination with inorganic coating materials. [0081] Coated and uncoated titanium dioxides of the invention may be used in the form of commercially available oily or aqueous predispersions. It may be advantageous to add dispersion aids and/or solubilization mediators. [0082] Suitable titanium dioxide particles and predispersions of titanium dioxide particles for the purposes of the present invention are obtainable under the following proprietary names from the stated companies: Additional ingredients of the Proprietary name Coating predispersion Manufacturer MT-150W None Tayca Corporation MT-150A None Tayca Corporation MT-500B None Tayca Corporation MT-600B None Tayca Corporation MT-100TV Aluminum Tayca Corporation hydroxide Stearic acid MT-100Z Aluminum Tayca Corporation hydroxide Stearic acid MT-100T Aluminum Tayca Corporation hydroxide Stearic acid MT-500T Aluminum Tayca Corporation hydroxide Stearic acid MT-lOGS Aluminum -- Tayca Corporation hydroxide - 22 - WO 2009/020676 PCT/US2008/058458 Additional ingredients of the Proprietary name Coating predispersion Manufacturer Laurie acid MT-100F Stearic acid Iron Tayca Corporation oxide MT-100SA Alumina Silica Tayca Corporation MT-500SA Alumina Silica Tayca Corporation MT-600SA Alumina Silica Tayca Corporation MT-100SAS Alumina Silica Tayca Corporation Silicone MT-500SAS Alumina Silica Tayca Corporation Silicone MT-500H Alumina Tayca Corporation MT-100AQ Silica Tayca Corporation Aluminum hydroxide Alginic acid Eusolex T Water Merck KgaA Simethicone Eusolex T-2000 Alumina Merck KgaA Simethicone Eusolex T-Olio F Silica C 12 1 5 Merck KgaA Dimethylsilate Alkylbenzoate Water Calcium Poly hydroxystearate Silica Dimethylsilate Eusolex T-Olio P Water Octyl Palmitate Merck KgaA Simethicone PEG-7 Hydrogenated Castor Oil Sorbitan Oleate Hydrogenated Castor Oil Beeswax Stearic acid Eusolex T-Aqua Water Alumina Phenoxyethanol Merck KgaA Sodium Sodium metaphosphate Methylparabens Sodium metaphosphate Eusolex T-45D Alumina Isononyl Merck KgaA Simethicone Isononanuate Polyglyceryl Ricinoleate Kronos 1171 None Kronos (Titanium dioxide 171) Titanium dioxide P25 None -- Degussa - 23 - WO 2009/020676 PCT/US2008/058458 Additional ingredients of the Proprietary name Coating predispersion Manufacturer Titanium dioxide Octyltri- Degussa T805 methylsilane (Uvinul TiO 2 ) UV-Titan X610 Alumina Kemira Dimethicone UV-Titan X170 Alumina Kemira Dimethicone UV-Titan X161 Alumina Silica Kemira Stearic acid UV-Titan M210 Alumina Kemira UV-Titan M212 Alumina Glycerol Kemira UV-Titan M262 Alumina Kemira Silicone UV-Titan M160 Alumina Silica Kemira Stearic acid Tioveil AQ I0PG Alumina Silica Water Propylene Solaveil Uniquema glycol Mirasun TiW 60 Alumina Silica Water Rhone-Poulenc [0083] The titanium dioxides of the invention are distinguished by a primary particle size between 10 nm to 150 nm. [0084] Titanium dioxides particularly preferred for the purposes of the present invention are MT- 100 Z and MT- 100 TV from Tayca Corporation, Eusolex T-2000 from Merck and titanium dioxide T 805 from Degussa. [0085] Further advantageous pigments are latex particles. Latex particles which are advantageous according to the invention are described in the following publications: U.S. Pat. No. 5,663,213 and EP 0 761 201. Particularly advantageous latex particles are those formed from water and styrene/acrylate copolymers and available for example under the proprietary name "Alliance SunSphere" from Rohm & Haas. [0086] An advantageous organic pigment for the purposes of the present invention is 2,2' methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl- )phenol) (INCI: bis octyltriazol), which is obtainable under the proprietary name Tinosorb® M from CIBA Chemikalien GmbH. - 24 - WO 2009/020676 PCT/US2008/058458 [0087] It is particularly advantageous for the purposes of the present invention for particulate UV filter substances which are not already in the form of a predispersion first to be dispersed in one or more dialkyl naphthalates of the invention and for this basic dispersion then to be further processed. Whereas auxiliaries which may enter into unwanted interactions with other substances of the cosmetic or dermatological formulation are usually added for stabilization to commercially available predispersions, it is astonishingly possible to dispense with the addition of such stabilizers when preparing basic dispersions of the invention. [0088] The total amount of one or more water-soluble UV filter substances in the finished cosmetic or dermatological preparations is advantageously chosen from the range 0.01% by weight to 20% by weight, preferably from 0.1 to 10% by weight, in each case based on the total weight of the preparations. [0089] In accordance with still another important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with asymmetrically substituted triazine UV filter compounds and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative. [0090] Asymmetrically substituted triazine derivatives display a good light protection effect. Their main disadvantage is, however, that their solubility is low in conventional oil components. Well-known solvents can dissolve only up to a maximum of 15% by weight of these compounds, which usually corresponds to a concentration of about 1 to 1.5% by weight of dissolved (=active) filter substance in the complete cosmetic or dermatological preparation. [00911 One disadvantage of the prior art is accordingly that generally only comparatively low sun protection factors have been achievable with these filter substances because their solubility or dispersibility in the formulations is too low, i.e. they can be satisfactorily incorporated into such formulations only with difficulty or not at all. [0092] Even if it is also possible in principle to achieve a certain UV protection when the solublity is limited, another problem frequently occurs, that is recrystallization. Substances of low solubility in particular recrystallize comparatively rapidly, which may be induced by fluctuations in temperature or other influences. Uncontrolled recrystallization of an essential - 25 - WO 2009/020676 PCT/US2008/058458 ingredient of a preparation such as a UV filter has, however, extremely disadvantageous effects on the properties of the given preparation and, not least, on the desired light protection. [00931 It was an object of the present invention to obtain in a simple manner preparations which are distinguished by an increased content of asymmetrically substituted triazine derivatives and a correspondingly high sun protection factor. [0094] Disadvantages of the prior art are remedied by active ingredient combinations effective for light protection and composed of: (a) one or more UV filter substances selected from the group of asymmetrically substituted triazine derivatives, and (b) one or more alkoxycrylenes having the structural formula (I); and (c) optionally a dibenzoylmethane derivative and/or a dialkyl naphthalate. [0095] Advantageous asymmetrically substituted s-triazine derivatives within the meaning of this embodiment of the present invention are, for example, those described in EP-A-570 838, whose chemical structure is represented by the generic formula 0 (0 CNil N N1 C R-NH Q-R NH NHl C 'X-R2 where R is a branched or unbranched CI-Cis-alkyl radical, a C 5
-C
12 -cycloalkyl radical, optionally substituted by one or more CI-C 4 -alkyl groups, and X is an oxygen atom or an NH group, - 26 - WO 2009/020676 PCT/US2008/058458 R I is a branched or unbranched CI-Cis-alkyl radical, a C 5
-C
1 2 -cycloalkyl radical, optionally substituted by one or more CI-C 4 -alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group of the formula A-fO-cI2-cr-l in which A is a branched or unbranched CI-Cis-alkyl radical, a C 5
-C
1 2 -cycloalkyl or aryl radical, optionally substituted by one or more CI -C 4 -alkyl groups,
R
3 is a hydrogen atom or a methyl group, n is a number from I to 10,
R
2 is a branched or unbranched CI-Cis-alkyl radical, a C 5
-C
1 2 -cycloalkyl radical, optionally substituted by one or more CI-C 4 -alkyl groups, and if X is the NH group, a branched or unbranched CI-Cis-alkyl radical, a C 5
-C
1 2 -cycloalkyl radical, optionally substituted by one or more CI-C 4 -alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group of the formula A-O-CH,-CH in which A is a branched or unbranched CI-Cis-alkyl radical, a C 5
-C
1 2 -cycloalkyl or aryl radical, optionally substituted by one or more Ci-C 4 -alkyl groups,
R
3 is a hydrogen atom or a methyl group, n is a number from 1 to 10, if X is an oxygen atom. [0096] In a preferred form of this triazine embodiment, the compositions are sunscreen, cosmetic or dermatological formulations that include a content of least one asymmetrically substituted s-triazine selected from the group of substances having the following structural formula: - 27 - WO 2009/020676 PCT/US2008/058458 OH NON OH N
A
1 Oil _N 1 jN o NO N OHl QNQ [0097] All the bisresorcinyltriazines, are advantageous for this embodiment of the purpose of the present invention. R 4 and R 5 are very particularly advantageously selected from the group of branched or unbranched alkyl groups of 1 to 18 carbon atoms. The alkyl groups may also again advantageously be substituted by silyloxy groups. [0098] A, is advantageously a substituted homocyclic or heterocyclic aromatic five membered ring or six-membered ring. [0099] The following compounds are very particularly advantageous: Oil N N OHl R4-O)6
O-R
5 where R 6 is a hydrogen atom or a branched or unbranched alkyl group with 1 to 10 carbon atoms, in particular 2,4-bis { [4-(2-ethylhexyloxy)-2-hydroxyjphenyl I -6-(4-methoxyphenyl) - 28 - WO 2009/020676 PCT/US2008/058458 1,3,5-t riazine (INCI: aniso triazine), which is obtainable under the proprietary name Tinosorb* S from CIBA-Chemikalien GmbH and is characterized by the following structure: [00100] Also advantageous is 2,4-bis{[4-(3-sulfonato-2-hydroxypropyloxy)-2 hydroxy]phenyl}I-6-(4-methoxy pheny)-1,3,5-triazine sodium salt, which is characterized by the following structure: 0 OH N OHf ONO NaO,;S SOIga On (H [0100] Also advantageous is 2,4-bis{[4-(3-(2-propyloxy)-2-hydroxypropyloxy)-2 hydroxy]phenyl } -6(4-meth oxyphenyl)- 1,3,5-triazine, which is characterized by the following structure: O1 O OH N Oi Oi Oil - 29 - WO 2009/020676 PCT/US2008/058458 [01011 Also advantageous is 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxyIphenyl}-6-[4-(2 methoxyethoxycarbon yl)phenylamino]-1,3,5-triazine, which is characterized by the following structure: Nflat NH [0102] Also advantageous is 2,4-bis{[4-(3-(2-propyloxy)-2-hydroxypropyloxy)-2 hydroxyIphenyl 1-6-[4-(ethoxycarbonyl)phenylamino]-1,3,5-triazine which is characterized by the following structure: NH OH N0 OH OH [0103] Also advantageous is 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(1 methylpyrrol-2-yl)1,3, 5-triazine, which is characterized by the following structure: -E 30 -30 - WO 2009/020676 PCT/US2008/058458 [0104] Also advantageous is 2,4-bis{[4-tris(trimethylsiloxysilylpropyloxy)-2 hydroxyiphenyl }-6-(4-meth oxyphenyl)- 1,3,5-triazine, which is characterized by the following structure: CHO il N Oi CH C-- C 0 0 ClC-s-i HC iO- iO-i-H C1 3 CI; [01051 Also advantageous is 2,4-bis{[4-(2-methylpropenyloxy)-2-hydroxy]phenyl}-6-(4 methoxyphenyl)-1,3,5-triazine, which is characterized by the following structure: On1 N 7 N Off 0 [0106] Also advantageous is 2,4-bis{[4-(1',1',1',3',5',5',5'-heptamethylsiloxy-2 methylpropyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine, which is characterized by the following structure: -31 - WO 2009/020676 PCT/US2008/058458 O 00 CH, OH ,jN OHR CR3 ONO C--- i 0 -CH O CH CH 3 0 CHI Clh [0107] In a particularly preferred embodiment, the present invention relates to cosmetic or dermatological formulations with a content of an asymmetrically substituted s-triazine whose chemical structure is represented by the formula N N Nl H13C CHT 3 iIjj which is also referred to hereinafter as dioctylbutylamidotriazone (INCI) and is obtainable under the proprietary name UVASORB HEB from Sigma 3 V. [0108] The asymmetrically substituted s-triazine derivative(s) of the invention are advantageously incorporated into the oil phase of the cosmetic or dermatological formulations. [0109] The total amount of one or more asymmetrically substituted s-triazine derivatives, in particular of dioctylbutylamidotriazone, in the finished cosmetic or dermatological - 32 - WO 2009/020676 PCT/US2008/058458 preparations is advantageously chosen from the range from 0.1 to 15.0% by weight, preferably 0.5 to 10.0% by weight, based on the total weight of the preparations. [0110] The cosmetic or dermatological light protection formulations of the invention may have conventional compositions when used for cosmetic or dermatological light protection and for the treatment, care and cleansing of skin and/or the hair and as a make-up product in decorative cosmetics. [0111] In accordance with one important embodiment, an alkoxycrylene of formula (I) is combined in a sunscreen or dermatological formulation with a lipophilic oxidation or UV sensitive active ingredients, such as retinoic acid and its derivatives, e.g., tretinoin or isotretinoin and/or a broad-band filter compound and optionally, but preferably, together with a dibenzoylmethane derivative. [0112] Advantageous lipophilic active ingredients which are stabilized in an excellent manner by the use according to the invention are those whose log P value is greater than 3.5. P is the partition coefficient, which is defined as the ratio of the equilibrium concentration of a dissolved substance in a two-phase system which consists of two solvents which are essentially immiscible with one another. These two solvents are, in the present case, n octanol and water, i.e. P., = C"7-OCtanol Cwater [0113] It is advantageous for the purposes of the present invention to choose the lipophilic active ingredients from the group of ubiquinones and plastoquinones. For the purposes of the present invention, coenzyme Q1O, which has a log P value of about 15, is very particularly advantageous. [0114] It was particularly surprising that very advantageous preparations according to the present invention can be obtained when the active ingredient(s) is/are chosen only from the group of ubiquinones. [0115] Further lipophilic active ingredients which are advantageous according to the invention are retinoids (vitamin A acid and/or derivatives thereof) or vitamin A and/or derivatives thereof. The group of retinoids advantageous according to the invention is defined - 33 - WO 2009/020676 PCT/US2008/058458 as including all cosmetically and/or pharmaceutically acceptable retinoids, including retinol and its esters, retinal and also retinoic acid (vitamin A acid) and esters thereof. For the purposes of the present invention, retinol (with a log P value of about 7) and retinyl palmitate (with a log P value of about 13) are particularly advantageous. [0116] It was also particularly surprising that very advantageous preparations can be obtained according to the present invention when the active ingredient(s) is/are chosen only from the group of retinoids. [0117] Further lipophilic acid ingredients advantageous according to the invention are carotenoids. For the purposes of the present invention, .beta.-carotene, which has a log P value of 15, for example, is particularly advantageous. [0118] Further lipophilic active ingredients advantageous according to the invention are: lipoic acid and derivatives, vitamin E and derivatives, vitamin F, dioic acid [8-hexadecene 1,16-dicarboxylic acid (CAS number 20701-68-2)] [0119] The amount of lipophilic active ingredients (one or more compounds) in the preparations is preferably 0.0001 to 10% by weight, particularly preferably 0.001 to 5% by weight, based on the total weight of the preparation. [0120] Synthesis of methyl or ethyl 2-cyano-3-(4'-methoxyphenyl)-3-phenylpropenoate (Methyl or Ethyl Methoxycrylene or Methyl or Ethyl MeOcrylene) 0 0 N -- -- N - O (or the ethyl cyanoacetate) 0 AcOH/toluene/NH 4 OAc 0 reflux, 24-26 h 0 4-Methoxy benzophenone (MW=182.22 g/mole; 500g; 2.74 mole; 1 mole equivalence) and methyl cyanoacetate (MW=99.09 g/mole; 367.06 g; 3.70 mole; 1.35 mole equivalence) were placed in 1-L 3-neck flask assembled with mechanical stirrer and nitrogen inlet, which provided continuous flow of nitrogen through the reaction mixture (nitrogen is bubbled through the reaction mixture). Next, toluene (1200 ml) and acetic acid (240 ml; ratio of - 34 - WO 2009/020676 PCT/US2008/058458 toluene/acetic acid = 5/1) are added to the flask followed by ammonium acetate (MW=77.09 g/mole; 21.12g; 0.274 mole, 0.1 mole equivalence; the catalyst is added 4 times this amount during reaction time). The flask is then assembled with Dean-Stark receiver through which reaction water is being continuously removed. Comments: 1. Aliquots of the reaction mixture are taken to check the rate of completion of the reaction. 2. The amount of water expected from this reaction is 49.5 ml. However, I collected about 120 ml of water phase. This is due to the fact that the water is distilled in form of a mixture, water/acetic acid/toluene. 3. To prevent from loosing the methyl acetate from the reaction mixture, it helps to put a short packed column between Dean-Stark receiver and the flask. [0121] Work-up: The reaction mixture is cooled to room temperature and ethyl acetate is added to dissolve all solids before the crude mixture is washed several time with water, to remove acetic acid and salts. The solvents are then removed from the reaction mixture by distillation. The crude solid product is re-crystallized from hot methanol (or toluene/methanol mixture, if such is preferred). [0122] Comments: The finished product begins to crystallize out from the cooling reaction mixture and thus can be filtered off, but it still is very acidic, so the crystals ought to be washed with water/methanol mixture to wash out any acetic acid and salts residues. Thus obtained the product then can be re-crystallized and the mother liquor can be washed with water, dried, and second crop of the product can be obtained. [0123] Synthesis of Alkyl 2-cyano-3-(4'-methoxyphenyl)-3-phenylpropenoate: O 0 0 BuSn(OH)CI 0 R + HO R 2 180C 0 I 0 3 -35- WO 2009/020676 PCT/US2008/058458 [0124] Reaction Procedure: Methyl (or ethyl) 2-cyano-3-(4'-methoxyphenyl)-3-phenylpropenoate (900g, 3.06 mole; MW = 293.32), alkyl alcohol (3.84 mole; 1.25 mole equivalence), and Tegokat 250 (0.03 % of total batch weight) were placed in 2 L 3-neck round-bottom flask and heated to temperature set at 185 C (365 F), with nitrogen purging it well to remove forming methanol (or ethanol) via the simple distillation setup with packed column. After 3 h, GC showed full conversion of methyl 2-cyano-3-(4'-methoxyphenyl)-3 phenylpropenoate to the desired product. [0125] Work-up: The unreacted alkyl alcohol was completely removed by vacuum distillation. Temperature of the reaction was lowered to 110 C (230 F) and calculated amount (2% of total batch weight) of the SSP (tin removing agent) was added. The product was stirred at this temperature for 2 hours and then filtered hot. Small amount of celite was added right before filtration to enhance the filtration - with celite the filtration was more efficient and faster. [0126] Results: Yield of the product ---------------- 94% of stoichiometric amount Purity of finished product ----------- 99.8 1% (area count, GC). EXAMPLES [0127] The following compositions (Table I) were prepared according to the procedure indicated in order to show the surprisingly superior photostabilizing effect on avobenzone of the alkoxycrylenes (4.5 wt.%) described herein in comparison to an equimolar amount (2.75 wt.%) of octocrylene. The compound described as "methoxycrylene" had the following formula (IV):
CH
3 -0 COOR 3 (IV) =C/ C~~N ,wherein R 3 = C 20 - 36 - WO 2009/020676 PCT/US2008/058458 0) 0D 0 0 0 0 o~ 0 0 (0 0 : 010 0 0 o I& 0 L 0 0 0 0 0 0 0 0 , ) 00 0o 0 0t 0 0 0 0 L .0 ml ID -o N 0 - 0 I0 0 )o 0 'o ( 0 ( 0 l 00 0 0 0 0DL L 0 0 0 C) i 0) C r:c ,c 00 0 N 0 ' t., 7 o o 0o 00 ( 0(0(00 tI I C) UC . 0 E CU a)C O 01N 0 '00--- co0 0 o "t 0~ o N'JN 'NC~( 0 0 o 0 i ; L 0M E E.2 c C (0 0 ElE 01- o E o C! 00o -.-- K. 0- o e-9e U)) o- (00 0 (00 00010 0 ) 0~ 0) o0 Lo 0 0 ;00 0 oc L -l c~L)00 000C OO t 0~0 CJ C'J'J 01--0 00c z 'It. lo NI L: 0 ( 0 0 a C' a) x 00 0 i o 00 0 f 0 0 O 0I~~ (0: O I~ I 'a- 0 rW 0 I a) - 0 G) w LLOO EEE C r! a) CC 4) - T 0,~~ .
2 0 CE2 C~: 0 -=r6 C 0 7 0 C 0 I0 ,x00 0 o >I~ llU.-o~~ c- Er ECw 4) > D 0 0 >, . 0 M I IC > ~ ~ ~ ~ ~ - 380- l z0c WO 2009/020676 PCT/US2008/058458 [0128] The surprising photostability of the sunscreen composition of Example 1, Table I, including methoxycrylene, in comparison to the octocrylene of the prior art, is shown in Fig. 1, which is a graph of the data of Examples 1 through 3, above, and in the following SPF reports for Examples 4-6. - 38 - WO 2009/020676 PCT/US2008/058458 ii~ 1-i1 00 C ) c o o 0) do 00 0) O0 Lo ( 00~ 0Ln000C 0 1 10-00 0 0LO 'I0w 0) ol- 00ci I 10 0 0 - O 1 0 ;co 010 001j0l1000N C0CCt -000 ~ ~ 0 10n - (3 04 -It 0 10O 1 C'1 N 100 0 1 x-0 0 3 0 0a (0 0, 0 w.20 10 jJR- 0 0 C0 a)) It C; a) :N LOI 0 ir c a)0 O 0 - 0 , fll 0or a) 10 00 :** * W 000~00 1001 000100 (D C W~ ~ a)E) C 0-- E ac (D 00 co 0. p E2 0 E cc CYIa 0 a~0( E -a M C < II I 'S o aa) C6 :s -UJ 0O I-o a) (3 LLI 0O 0 03 0< 0<.a 0- '0 6" oI~ 4) a) a) a 0 0 CL a O ~ 0 cu w u U) M Z) j5 a =~~-6 to) .- 0 lt ~~~I~C iL _ O x a ::: ILL 0 U)N O~~3I2.~ 5, 031 1-04 o c WO 2009/020676 PCT/US2008/058458 [0129] Additional alkoxycrylene molecules were tested in accordance with the procedure indicated in Table 2, wherein radical R 3 of the alkoxycrylene of formula (1) has an R 3 = ethyl hexyl (formula IV): COO -CH 2
-CH
2
-CH
2
-CH
2
-CH
2
-CH
3 (IV) C~N
CH
2
CH
3 The data for the sunscreen composition of Example 4 is shown in the graph of Fig. 2 and the data for the composition of Example 5 is shown in the graph of Fig. 3. For Examples 4-6, the data of Example 6 (shown in graph form as Fig. 4) compares 7% ethylhexyl methoxycrylene (formula V) and 1.8% octocrylene (Example 4) to 8.8% octocrylene with no alkoxycrylene. As shown in the graph of Fig. 4 and the following SPF reports for Examples 4-6, the alkoxy crylenes described herein are unexpectedly better photostabilizers than octocrylene. SPF REPORT Sample: Example 4 UV Photostability Comment: 0, 35 MED Wavelength Range: 290 - 400 nm Units: SPF T(UVA) T(UVB) # of Scans: 2 2 2 Mean: 24.67 4.52% 5.43% STD: 1.83 0.83% 0.35% COV: 7.43% 18.26% 6.46% UVA/UVB Ratio: 1.1 Boots Star Rating: N/A less than 5 Scans Scan # SPF Critical Wavelength 25.97 385 2 23.37 384 - 40 - WO 2009/020676 PCT/US2008/058458 SPF REPORT Sample: Example 5 UV Photostability Comment: 0, 35 MED Wavelength Range: 290 - 400 nm Units: SPF T(UVA) T(UVB) # of Scans: 2 2 2 Mean: 16.76 23.10% 8.07% STD: 11.8 18.59% 4.20% COV: 70.42% 80.47% 52.01% UVA/UVB Ratio: 0.72 Boots Star Rating: N/A less than 5 Scans Scan # SPF Critical Wavelength 25.11 380 2 8.41 372 SPF REPORT Sample: Example 6 UV Photostability Comment: 0, 35 MED Wavelength Range: 290 - 400 nm Units: SPF T(UVA) T(UVB) # of Scans: 2 2 2 Mean: 23.83 11.80% 5.27% STD: 3.81 6.61% 0.24% COV: 16.00% 55.96% 4.51% UVA/UVB Ratio: 0.88 Boots Star Rating: N/A less than 5 Scans Scan # SPF Critical Wavelength 1 26.52 382 2 21.13 375 [01301 As shown in the above-referenced formulations and data of Examples 4-6, the combination of avobenzone (UVA) with octylmethoxycinnamate (UVB) has particularly surprising results when combined with a stabilizing amount of an alkoxycrylene of formula I. It is well know that octocrylene stabilizes octyl methoxycinnamate (OMC), a UVB filter, but does not photostabilizer avobenzone, a UVA filter. In accordance with the compositions and methods described herein, it has been found that the alkoxycrylene of formula I photostabilize octyl methyoxycinnemate (OMC) much better than OMC, and also photostabilizes avobenzone. The alkoxycrylenes, therefore, can photostabilize sunscreen - 41 - WO 2009/020676 PCT/US2008/058458 compositions. Accordingly, by adding an alkoxycrylene, both avobenzone and OMC can be photostabilized by the alkoxycrylene. [0131] Example 4 (7% alkoxycrylene and 1.8% octocrylene) loses only 18.26% UVA; 6.46% UVB; and 7.43% of its SPM when subjected to 35 MED irradiation. The same formulation containing no alkoxycrylene (Example 5) loses 80.47% UVA; 52.01% UVB; and 70.42% of its SPF. Example 6, containing 8.8% octocrylene and no alkoxycrylene loses 55.96% UVA; 4.51% UVB (octocrylene photostabilizes OMC but not avobenzone); and 16% of its SPF, Examples 4,5 and 6 are shown graphically in Figures 2, 3 and 4. [0132] Additional sunscreen compositions were prepared containing 0 wt.%, 3 wt.% and 5 wt.% 2-ethylhexyl methoxycrylene, as shown in Examples 7-10 in Table 3: - 42 - WO 2009/020676 PCT/US2008/058458 Table 3 Example 7 Example 8 Example 9 Example 10 # Ingredients (5% 2-EH (3% 2-EH (0% 2-EH (3% 2-EH Methoxycrylene) methoxycrylene) methoxycrylene methoxycrylene) Oil Phase Ingredients 1 Avobenzone 3.00% 3.00% 3.00% 3.00% 2 Octisalate 5.00% 5.00% 5.00% 5.00% 3 Octinoxate (Octyl methoxycinnamate or OMC or 7.50% 7.50% 7.50% 7.50% MCX) 4 Benzophenone-3 0.49% 0.49% 0.49% 0.49% 5 Octocrylene*** (OC) 5.00% 7.00% 10.00% 10.00% 6 Ethylhexyl methoxycrylene*** (2-EH 5.00% 3.00% 0.00% 3.00% methoxycrylene or MOC) 7 Cetearyl alcohol 0.35% 0.35% 0.35% 0.35% 8 C30-38 Olefin/Isopropyl maleate/MA copolymer 0.80% 0.80% 0.80% 0.80% Total Oil Ingredients 27.14% 27.14% 27.14% 30.14% Emulsifiers 9 Steareth-21 0.45% 0.45% 0.00% 0.00% 10 Steareth-2 0.65% 0.65% 0.00% 0.00% 11 Glyceryl stearate/PEG-1 00 stearate 0.00% 0.00% 1.00% 1.00% 12 Potassium cetyl phosphate & Hydrogenated palm 3.00% 3.00% 3.00% 3.00% glycerides Total Emulsifiers 4.10% 4.10% 4.00% 4.00% x Water Phase Ingredients 13 Disodium EDTA 0.10% 0.10% 0.10% 0.10% 14 Tromethamine 0.04% 0.04% 0.04% 0.04% 15 Glycerin 4.00% 4.00% 4.00% 4.00% 16 Benzyl alcohol 1.00% 1.00% 1.00% 1.00% 17 Methylparaben 0.10% 0.10% 0.10% 0.10% 18 Propylparaben 0.05% 0.05% 0.05% 0.05% 19 Water 58.47% 58.47% 58.57% 55.57% Total Water Ingredients 63.76% 63.76% 63.86% 60.86% Other Ingredients 20 Acrylamide/Sodium acryloyldimethyltaurate copolymer (and) Isohexadecane (and) Polysorbate 80 2.00% 2.00% 2.00% 2.00% 21 Aluminum starch octenyl succinate 3.00% 3.00% 3.00% 3.00% Total Other Ingredients 5.00% 5.00% 5.00% 5.00% Total 100.00% 100.00% 100.00% 100.00% PROCEDURE 1. Charge secondary vessel with 1-9. With stirring, heat to 900 C. Add in order 9-12. Continue stirring until homogeneous. 2. Charged primary vessel with water (19). With stirring, add 14-15. Heat to 9Q0 C 3. Add oil phase (1-8, 9-12) to water phase (19, 14, 15). Stir vigorously for 10 minutes. Switch to homomixer and homogenize until temperature is below 600 C. 4. When temperature of emulsion is below 60" C, switch to sweep stirring. Preblend 15-18. Add to emulsion when temperature is below 450 C 5. Add 20 and continue sweep stirring as emulsion thickens. When smooth, add 21. 6. QS. water and package when temperature of batch is less than 350 C. Q.S. =quantity sufficient - 43 - WO 2009/020676 PCT/US2008/058458 [0133] The results were as follows and clearly show that adding more alkoxycrylene to sunscreen formulation provides more Photostabilization of both UVA and UVB filters. Example 7, having the most MOC (5%) and the least OC (5%) provided the best results. Example 7 Example 8 Example 9 Example 10 Results of Irradiation with 20 MED 5% OC/5% MOC 7% OC/3% MOC 10% OC/0% MOC 10% OC/3% MOC UVA1/UV ratio before UV irradiation 0.84 0.83 0.79 0.83 UVA1/UV ratio after 20 MED 0.76 0.71 0.54 0.70 Difference after irradiation 0.09 0.12 0.25 0.13 % change 10.00% 15.00% 32.00% 16.00% OC=Octocrylene; MOC=Ethylhexyl Methoxycrylene; UVA1 =total area under curve from 340 to 400nm; UV=total area under curve from 290 to 400nm [0134] More sunscreen compositions were prepared containing 0, 2, 4 and 6 wt.% 2-ethylhexyl methoxycrylene to test the photostabilizing capacity of the methoxycrylenes to photostabilize avobenzone and other photodegradable UV-absorbers, as shown in Examples 11-14 in Table 4: Table 4 Example 11 Example 12 Example 13 Example 14 # Ingredients 0% MOC 2% MOC 4% MOC 6% MOC Oil Phase Ingredients |_|_|_| 1 Avobenzone 3.00% 3.00% 3.00% 3.00% 2 Octisalate 5.00% 5.00% 5.00% 5.00% 3 Homosalate 7.50% 7.50% 7.50% 7.50% 4 Butyloctyl benzoate 9.00% 7.00% 5.00% 3.00% 5 Ethylhexyl methoxycrylene*** (2-EH methoxycrylene or MOC) 0.00% 2.00% 4.00% 6.00% 6 Cetearyl alcohol 0.35% 0.35% 0.35% 0.35% 7 VP/Eicosene copolymer 1.00% 1.00% 1.00% 1.00% Total Oil Ingredients 25.85% 25.85% 25.85% 25.85% Emulsifiers 8 Steareth-21 0.00% 0.00% 0.00% 0.00% 9 Steareth-2 0.00% 0.00% 0.00% 0.00% 10 Glyceryl stearate/PEG-100 stearate, 1.00% 1.00% 1.00% 1.00% 11 Potassium cetyl phosphate & Hydrogenated palm glycerides 3.00% 3.00% 3.00% 3.00% Total Emulsifiers 4.00% 4.00% 4.00% 4.00% x Water Phase Ingredients 12 Disodium EDTA 0.10% 0.10% 0.10% 0.10% 13 Glycerin 4.00% 4.00% 4.00% 4.00% 14 Benzyl alcohol 1.00% 1.00% 1.00% 1.00% 15 Methylparaben 0.10% 0.10% 0.10% 0.10% 16 Propylparaben 0.05% 0.05% 0.05% 0.05% 17 Water 59.90% 59.90% 59.90% 59.90% Total Water Ingredients 65.15% 65.15% 65.15% 65.15% Other Ingredients 18 Acrylamide/Sodium acryloyldimethyltaurate copolymer (and) Isohexadecane (and) Polysorbate 80 2.00% 2.00% 2.00% 2.00% 19 Aluminum starch octenyl succinate 3.00% 3.00% 3.00% 3.00% Total Other Ingredients 5.00% 5.00% 5.00% 5.00% Total 100.00% 100.00% 100.00% 100.00% PROCEDURE 1. Charge secondary vessel with 1-7. With stirring, heat to 900 C. Add in order 10-11. Continue stirring until homogeneous. - 44 - WO 2009/020676 PCT/US2008/058458 Example 11 Example 12 Example 13 Example 14 # Ingredients 0% MOO 2% MOC 4% MOC 6% MOC 2. Charged primary vessel with water (17). With stirring, add 12. Heat to 90 C 3. Add oil phase (1-7, 10-11) to water phase (17, 12). Stir vigorously for 10 minutes. Switch to homomixer and homogenize until temperature is below 60* C. 4. When temperature of emulsion is below 60* C, switch to sweep stirring. Preblend 13-16. Add to emulsion when temperature is below 450 C 5. Add 18 and continue sweep stirring as emulsion thickens. When smooth, add 19. 6. Q.S. water and package when temperature of batch is less than 350 C. O.S. =quantity sufficient [0135] The results were as follows: Example 11 Example 12 Example 13 Example 14 Results of Irradiation with 20 MED 0% MOC 2% MOC 4% MOC 6% MOC UVA1/UV ratio before UV irradiation 0.88 0.91 0.90 0.91 UVA1I/UV ratio after 20 MED 0.32 0.85 0.88 0.90 Difference after irradiation 0.56 0.06 0.02 0.01 % change 63.67% 6.43% 2.00% 1.04% MOC=Ethylhexyl Methoxycrylene; UVA1 =total area under curve from 340 to 400nm; UV=total area under curve from 290 to 400nm [0136] It should be noted that the sunscreen formulations of Examples 11-14 contain no octyl methoxycinnemate or other photostabilizers. It is clear from the data of Examples 11-14 that the alkoxycrylene of formula I photostabilize avobenzone and other dibenzoylmethane derivatives with surprising efficacy. [0137] Additional sunscreen compositions were prepared containing 5 wt.% 2-ethylhexyl methoxycrylene with and without 1.5 wt.% Tinosorb S or Tinosorb M, as shown in Examples 15 and 16 in Table 5: Table 5 Example 15 Example 16 # Ingredients 1.5% Bemotrizinol/5% 5% Bisoctrizole/5% MOC MOC Oil Phase Ingredients 1 Avobenzone 3.00% 3.00% 2 Octisalate 5.00% 5.00% 3 Octinoxate (Octyl methoxycinnamate or OMC or MCX) 7.50% 7.50% 4 Bemotrizinol (Tinosorb S) 1.50% 0.00% 6 Ethylhexyl methoxycrylene*** (2-EH methoxycrylene or MOC) 5.00% 5.00% 7 Trideceth-12 1.00% 1.00% 8 VP/Eicosene copolymer 1.00% 1.00% 9 Behenyl alcohol + Glyceryl stearate + Glyceryl stearate citrate + Sodium dicocoylethylenediamine PEG-15 sulfate 1.00% 1.00% Total Oil Ingredients 25.00% 23.50% Emulsifiers - 45 - WO 2009/020676 PCT/US2008/058458 Example 15 Example 16 # Ingredients 1.5% Bemotrizinol/5% 5% Bisoctrizole/5% MOC MOC (See 7,9,12) 0.00% 0.00% Total Emulsifiers 0.00% 0.00% x Water Phase Ingredients 10 Disodium EDTA 0.10% 0.10% 11 Xanthan gum 0.10% 0.10% 12 Sodium dicocoylethylenediamine PEG-15 sulfate + Sodium lauroyl 1.00% 1.00% lactylate 13 Glycerin 4.00% 4.00% 14 Benzyl alcohol 1.00% 1.00% 15 Methylparaben 0.10% 0.10% 16 Propylparaben 0.05% 0.05% 17 Water 63.65% 60.15% Total Water Ingredients 70.00% 66.50% Other Ingredients 18 Bisoctrizole (Tinosorb M) 0.00% 5.00% 19 Acrylamide/Sodium acryloyldimethyltaurate copolymer (and) Isohexadecane (and) Polysorbate 80 2.00% 2.00% 20 Aluminum starch octenyl succinate 3.00% 3.00% Total Other Ingredients 5.00% 10.00% Total 100.00% 100.00% PROCEDURE 1. Charge secondary vessel with 1-9. With stirring, heat to 70* C. Continue stirring until homogeneous. Maintain temperature. 2. Charged a third vessel with water (19). Dissolve 10 with stirring. Add 11 and stir until Xanthan gum is completely dissolved. 3. Place 1/3 of (2) in primary vessel. Heat to 654 C. Add 12 and stir until homogeneous. 4. Add oil phase (1-9) to water (10-12) in primary vessel. Homogenize for two minutes, or until emulsion is fully formed. 5. Remove batch from heat. Slowly add balance of water (see Step 2) to emulsion with stirring. Stir while cooling. 6. Preblend 13-16. Add to batch with stirring. Add 18 to batch with stirring. 7. Add 19 and stir until smooth and homogeneous. Add 20 and stir until fully incorporated. Q.S. water. Package when batch is < 354 C. Q.S. = quantity sufficient [01381 The results were as follows: Example 15 Example 16 Results of Irradiation with 20 MED 1.5% Bemotrizinol/5% MOC 5% Bisoctrizole/5% MOC UVA1/UV ratio before UV irradiation 0.87 0.87 UVA1/UV ratio after 20 MED 0.81 0.84 Difference after irradiation 0.06 0.03 % change 6.66% 3.55% MOC=Ethylhexyl Methoxycrylene; UVA1=total area under curve from 340 to 400nm; UV=total area under curve from 290 to 400nm - 46 - WO 2009/020676 PCT/US2008/058458 [0139] Tinsorb S of Examples 15 and 16 is a known UVA and UVB photostabilizer (more effective in the UVA range) for photostabilizing both avobenzone and octyl methoxycinnamate. Surprisingly, as shown in the data of Examples 15 and 16 (both Examples include 5% MOC) omitting the Tinsorb S from Example 16 makes very little difference in photostabilizing the combination of avobenzone and OMC. [0140] Additional sunscreen formulations were tested containing 5 wt.% butyloctyl methoxycrylene and a triazine derivative (Uvinul T-150); a benzophenone derivative (Uvinul A Plus); and three water soluble UV filters (Mexonylsx; Neo Heliopan AP; and Neo Heliopan Hydro), as shown in examples 17-21 of table 6: TABLE 6 Exa-ple17_ _ Examplei8 Example19 Example 20 Example21 ingredients 2% Uvinul T-150 2% Uvinul A Plus 2% Mexoryl SX 2% Ned Hellopan AP 2% Neo Heliopan Hydro Oil Phase Ingredients 1,ven n.0 3 00% 3.00% 300%.00% 2 Octialate 5.00 00O% 500% M%00% 3 Octnoxate (Octyrethroxycinnarmate or OMC 7MCXL 7O 750% 7.0% 750% 7,50% 4_Octyl triazone(Uvinul T-150, BASF) 2.00% 0 00% 00000%00% 0.00% 5 Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus, BASF) 0.00% 2.00% 0,00% 0.00% 000% Dtflcy ~trx5.00%1 5.00% 5.0%0500% 7VP/Ecosene co0!re 10m0% 0%10 Total Oil Ingredients 23.50% 23.50% 210% 2150% 21,50% | a1.00% .- 100% 1.00% 1.00% 9]Gcery st 100% 1000 1 00% 1 00% 10 Polygycer-3 methyl glucose dislearate 3 00% 3.00% 300% 3.00% 3,00% Total Emuisifiers 5,00% 00% 0 00% 50 00 11 Disdium EDTA 01 - 01 010% 1 0.10% 12 Ecamsule neutralized with triethanolamine (rlexoryl SX, Chemex) 0 00%M6 000% 2 .00% 0 00% l3 Bisdisulizole disodiurn (Neo Heliopan AP, Symrise) 00 000% 00 % 2.00% 000% 14[Ensulizole neutralize wilh triehanolmine (Neo Heliopan Hydro, Symise) 000 00% 0 00% 0.00% 2.00% 1_13Gycern._400% 4100% 4.00% 4.00% 4,00% 16|Benzyalcoho 100% 100% 1.00% 100% 1.00% 17|Metparaberr 0 10% 0,10% 0.10% 0.10% 0 10*o 18|Propylparaben 0 05% 005% 0.05% 0.06% 19 Water 6125% 6125% 612% 6125% _ __ 61.52% Total Water ngred ents 6650 6.50% 650% 6850% 68.50% Acryamidedium acrytoldimethytaurate copolyer (and) _______ 20tohexadecane (and) Potysorbate 80 -- 2-00*----- 2-00% 2.00% 2.00% 2,00% 21 Aluminum starch octenyl succinate 3 00% 3 00% 3.00% 3.00% Total Other Ingredients 5 00% 5,00% 5.00% 5.00% 5.00% Total 100000% 100.00% 100,00% 100.00% 100.00% -- PROCEDUR1E -....
Charge secondary essethl1 With strrin Seal to 80* . Add 8-10 Coninue sting untihomogenos 2. In another secondary vessel, dissolve 12 or 13 or 14 in water and set aside 3. Charged primary vessel with water (19), except amount necessary for Step 2.. Dissolve 11. Heat to 80*C=1 4. Add oil (1 -10) to water (11, 19) wtstrng Reoefmha.Hm gniefor 10 minutes. Stir while cooling 5. When temperature is below 45) C, add pre-mixed 15-18. 6Ad pr-dissolved 12, 13, or 14 7. Add 20 and continue swep stirring as emulsion thickens. When smooth, add 21, 8. Q.S& water and package when temperature of batch is less than 35* C, Q S, = quantity sufficient [0141] Two more sunscreen formulations (Examples 22 and 23) were prepared each containing butyloctyl methoxycrylene, and Example 23 also containing Tinosorb® S and Tinosorb* M. As shown in the results, the combination of an alkoxycrylene, together with a - 47 - WO 2009/020676 PCT/US2008/058458 dibenzoylmethane derivative, a cinnamate ester, Tinasorb* S and Tinasorb* M, avobenzone and octyl methoxycinnamate is particularly photostable: Example 22 Example 23__ Resus of irradain~ with 2 MAED 0% T3n&% Tin7 BMOC 2% TinS/ T-M5 BM UV1Ai3UV rtio before IN irrad<ae 4|08 UVA tUV rti after231ED078 j8 Differnc after tradiation10| 2 hnk % hane E14%| 2I35% UVAt2da a d curfrom 34D to 40nm UV- aa araur une ro 290 o 400am Exampl 22Eample 23 ___ Ingr edien ts 3% Thins% «iMS BMO4Y | 2% Tins&5% TinM/5% BIoc | 2P c h sIt - I ts 4|Be n Tin2 00% |~B< 7ndeM2 - 1 00%|4:- 4r~C< | |B r n a ddl o lyer impe + Glycerys staarate caraa + Toalox crnrediens o mr trm Total Emu:sifiers3~ |m1o|ecudyle uhe a nhe P G4 me derivmtivesady ate -i |NP rle 00%|teplystr disclosed~~~ate inas thi asigees S aetN.72557(57,hrb noprtdb |e13|Gnysi assow0n omua|V) | 1 |e l al |~ 16PoBaraben 0 5% 17 3WaterA 1" 582 % TotaW W ate agentss 64 50% 19< Arear- de:3<de .acrlcIdimay a. ae poyte(n s exadeae (and)P Iysroaa 8 .00 20 A>umim stcacenytI succnat 3 00%3 Totat Otherl'a ements -30 00 P O E'aURE 1 AdC 1 a d scr un smo i and3 3a hooeeous 'Ad 21 and se uar ful maarpora<'ted QA aer« aae whenp as<34C iiaa a . e>23 5 <3r.vir Ad~ana~uIKa r>.-aaIpey<I 3 a~1~ 2 -ae~ 'a 21 < ' i:unI I e I aaa aiI: :- 'I<a~s 1 Ic: zea-aa 't crI<ar.--I 'I~ a- C. .3a,, aa: acI aae~ e 2>- a-c a:-C3' -I |,Ie|< A ~~" Ii,8t~at: -- s-'<n 33%aa-~wt3 rar 3<A- -<' :'>-. '<3'atdra eers <a:23a-a 2321>iaI r:~e. o|a'- |3< ' o 43 Pia| | [042 n dito t hesmpeese akxycyln cmoud o orua I-|) the alox cyen mieis anbeatahe a neormoetemialmieie o poyse moeclesuhasth akxydeivtve o te i(NG ryee)Fuert |plystr references additown intoresml ese loxVrlnecmond ffrml)I-()h - 48 - WO 2009/020676 PCT/US2008/058458 A0 R 2 H A 0 R O R 3B (R 7)d 0 0 -(R )b (VI) S(R 6). wherein A and B are the same or different and are selected from the group consisting of oxygen, amino and sulfur; R I and R 3 are the same or different and are selected from the group consisting of CI-C 30 alkyl, C 2
-C
3 o alkylene, C 2
-C
30 alkyne, C 3
-C
8 cycloalkyl, CI-C 30 substituted alkylene, C 2
-C
30 substituted alkyne, aryl, substituted aryl, heteroaryl, heterocycloalkyl, substituted heteroaryl and substituted heterocycloalkyl; R 2 is selected from the group consisting of CI-C 30 alkyl, C 2
-C
30 alkylene, C 2
C
30 alkyne, C 3
-C
8 cycloalkyl, CI-C 30 substituted alkyl, C 3
-C
8 substituted cycloalkyl, C-C 30 substituted alkylene, C 2
-C
3 0 substituted alkyne; R 4, R , R6 and R 7 are the same or different and are selected from the group consisting of CI-C 3 0 alkoxy straight chain on branched, and a, b, c and d are each either 0 or 1, and a, b, c and d add up to 1, 2, 3, or 4. - 49 -

权利要求:
Claims (101)
[1] 1. A photostabilized photoactive composition comprising a mixture of a photoactive compound that develops a singlet excited state, or fluoresces when subjected to UV radiation and a singlet excited state quenching effective amount of a compound of formula (I): R, COOR 3 (I) R2 CN wherein at least one of R, and R 2 is a straight or branched chain CI-C 3 0 alkoxy radical, and any non-alkoxy R 1 or R 2 is hydrogen; and R 3 is a straight or branched chain CI-C 30 alkyl radical.
[2] 2. The photostabilized photoactive composition of claim 1, wherein R, is methoxy and R 2 is hydrogen.
[3] 3. The photostabilized photoactive composition of claim 1, wherein R2 is methoxy and R 1 is hydrogen.
[4] 4. The photostabilized photoactive composition of claim 2, wherein R 3 is a CI 2 -C 30 straight chain or branched alkyl.
[5] 5. The photostabilized photoactive composition of claim 1, wherein the compound of formula (I) is present in an amount in the weight range of 0.1% to 30%, based on the total weight of the composition.
[6] 6. The photostabilized photoactive composition of claim 5, wherein the compound of formula (I) is present in an amount in the weight range of 0.5% to 20%, based on the total weight of the composition. - 50 - WO 2009/020676 PCT/US2008/058458
[7] 7. The photostabilized photoactive composition of claim 6, wherein the compound of formula (I) is present in an amount in the weight range of 0.1% to 10%, based on the total weight of the composition.
[8] 8. The photostabilized photoactive composition of claim 7, wherein the compound of formula (I) is present in an amount in the weight range of 3% to 10%, based on the total weight of the composition.
[9] 9. The photostabilized photoactive composition of claim 1, wherein the photoactive compound is selected from the group consisting of p-aminobenzoic acid and salts and derivatives thereof; anthranilate and derivatives thereof; dibenzoylmethane and derivatives thereof; salicylate and derivatives thereof; cinnamic acid and derivatives thereof; dihydroxycinnamic acid and derivatives thereof; camphor and salts and derivatives thereof; trihydroxycinnamic acid and derivatives thereof; dibenzalacetone naptholsulfonate and salts and derivatives thereof; benzalacetophenone naphtholsulfonate and salts and derivatives thereof; dihydroxy-naphthoic acid and salts thereof; o-hydroxydiphenyldisulfonate and salts and derivatives thereof; p-hydroxdydiphenyldisulfonate and salts and derivatives thereof; coumarin and derivatives thereof; diazole derivatives; quinine derivatives and salts thereof; quinoline derivatives; hydroxyl-substituted benzophenone derivatives; naphthalate derivatives; methoxy-substituted benzophenone derivatives; uric acid derivatives; vilouric acid derivatives; tannic acid and derivatives thereof; hydroquinone; benzophenone derivatives; 1, 3, 5- triazine derivatives; disodium phenyl dibenzimidazole and salts thereof; terephthalyidene dicamphor sulfonic acid and salts and derivatives thereof; methylene bis benzotriazolyl tetramethylbutylphenol and salts and derivatives thereof; bis ethylhexyloxyphenol methoxyphenyl triazine and salts, diethylamino hydroxyl benzoyl and derivatives thereof; phenylbenzimidazole sulfonic acid and salts thereof; terephthalylidene dicamphor sulfonic acid and salts thereof; and combinations of the foregoing.
[10] 10. The photostabilized photoactive composition of claim 1, wherein the photoactive compound comprises a dibenzoylmethane derivative.
[11] 11. The photostabilized photoactive composition of claim 10, further including a cinnamate ester. - 51 - WO 2009/020676 PCT/US2008/058458
[12] 12. The photostabilized photoactive composition of claim 11, wherein the cinnamate ester is an ester of an alkoxycinnamate.
[13] 13. The photostabilized photoactive composition of claim 12, wherein the alkoxycinnamate ester is a methoxycinnamate ester.
[14] 14. The photostablized photoactive composition of claim 11, wherein the cinnamate ester is selected from the group consisting of 2-ethylhexyl p-methoxycinnamate, isoamyl p-methoxycinnamate, and a combination thereof.
[15] 15. The photostabilized photoactive composition of claim 12 wherein the cinnamate ester is 2-ethylhexyl p-methoxycinnamate.
[16] 16. The photostabilized photoactive composition of claim 13, wherein the dibenzoylmethane derivative comprises butylmethoxy dibenzoylmethane.
[17] 17. The photostabilized photoactive composition of claim 1, further including a naphthalene dicarboxylic acid ester in an amount of 0.1 to 10 wt%.
[18] 18. The photostabilized photoactive composition of claim 15, wherein the naphthalene dicarboxylic acid ester comprises a diethylhexyl 2,6-naphthalene dicarboxylic acid ester.
[19] 19. The photostabilized photoactive composition of claim 1, further including a salicylate or a derivative thereof in an amount of 0.1 to 10 wt%.
[20] 20. The photostabilized photoactive composition of claim 14, further including a salicylate or a derivative thereof in an amount of 0.1 to 10 wt%.
[21] 21. The photostabilized photoactive composition of claim 1, further including a benzophenone or a derivative thereof in an amount of 0.1 to 10 wt.%.
[22] 22. The photostabilized photoactive composition of claim 19, wherein the benzophenone comprises benzophenone-3 in an amount of 0.1 to 10 wt.%. - 52 - WO 2009/020676 PCT/US2008/058458
[23] 23. The photostabilized photoactive composition of claim 13, further including bis-ethylhexyloxyphenol methoxyphenyl triazine in an amount of 0.1 to 10 wt. %.
[24] 24. The photostabilized photoactive composition of claim 13, further including diethylhexyl syringylidene malonate in an amount of 0.1 to 10 wt.%.
[25] 25. The photostabilized photoactive composition of claim 1, wherein the photoactive compound comprises a 1,3,5-triazine derivative.
[26] 26. The photostabilized photoactive composition of claim 13, further including methylene bis-benzotriazoyl tetramethylbutyl phenol in an amount of 0.1 to 10 wt. %.
[27] 27. The photostabilized photoactive composition of claim 13, further including diethylamino hydroxybenzoyl hexylbenzoate in an amount of 0.1 to 10 wt. %.
[28] 28. The photostabilized photoactive composition of claim 13, further including disodium phenyldibenzylimidazole sulfonic acid in an amount of 0.1 to 10 wt. %.
[29] 29. The photostabilized photoactive composition of claim 13, further including 2 (methylbenzilidene)-camphor.
[30] 30. The photostabilized photoactive composition of claim 13, further including phenylbenzimidazole sulfonic acid or salt thereof in an amount of 0.1 to 10 wt.%.
[31] 31. The photostabilized photoactive composition of claim 10, wherein the photoactive compound comprises a dibenzoylmethane derivative selected from the group consisting of 2-methyldibenzoylmethane; 4- methyldibenzoylmethane; 4 isopropyldibenzoylmethane; 4-tert-butyldibenzoylmethane; 2,4-dimethydibenzoylmethane; 2 5- dimethydibenzoylmethane; 4,4-diispropyldibenzoylmethane; 4,4 dimethoxydibenzoylmethane; 4-tert-butyl-4-methoxdibenzoylmethane; 2-methyl-5-isopropy 4-methoxydibenzoylmethane; 2-methyl-5-tert-butyl-4-methoxydibenzoylmethane; 2,4 dimethyl-4-methoxydibenzoymethane; 2,6-dimethyl-4-tert-butyl-4-methoxydibenzolmthane, and combinations thereof. - 53 - WO 2009/020676 PCT/US2008/058458
[32] 32. The photostabilized photoactive composition of claim I further including 0.1 to 10 wt.% of a triplet quencher selected from the group consisting of octocrylene, methyl benzylidene camphor, diethylhexyl 2,6-naphthalate, diethylhexyl syringylidene malonate, and combinations thereof.
[33] 33. The photostabilized photoactive composition of claim 15 further comprising 0.1 to 10 wt.% benzophenone-3.
[34] 34. The photostabilized photoactive composition of claim 15 further comprising 0.1 to 10 wt.% octyl salicylate.
[35] 35. The photostabilized photoactive composition of claim 9, wherein the photoactive compound comprises a derivative of cinnamic acid.
[36] 36. The photostabilized photoactive composition of claim 14, wherein the photoactive compound comprises 2-ethylhexyl-p-methoxycinnamate.
[37] 37. The photostabilized photoactive composition of claim 13, wherein the photoactive compound comprises isoamyl methoxycinnamate.
[38] 38. The photostabilized photoactive composition of claim 1, that includes an ester of cyanodiphenyl propenoic acid.
[39] 39. The photostabilized photoactive composition of claim 1, wherein the mixture includes methyl benzylidene camphor.
[40] 40. The photostabilized photoactive composition of claim 1, wherein the composition includes a compound selected from the group consisting of methylene bis benzotriazolyl tetramethylbutylphenol, salts and derivatives thereof; bis-ethylhexyloxyphenol methoxyphenyl triazine, and salts and derivatives thereof;
[41] 41. The photostabilized photoactive composition of claim 1, wherein the composition includes a hydroxyl-substituted benzophenone derivative or a methoxy substituted benzophenone derivative, or a combination thereof. - 54 - WO 2009/020676 PCT/US2008/058458
[42] 42. The photostabilized photoactive composition of claim 1, further comprising a diester or polyester of naphthalene dicarboxylic acid selected from the group consisting of compounds of formula (II) and (III), and combinations thereof: HO--R 3 -0 2 C CO 2 -- R 4 -OH (11) m R 1 0 2 C -- C0 2 {-R 4 -CO 2 - -CO2- -R 2 (1II) - n wherein R, and R 2 are the same or different and selected from the group consisting of C 1 -C 22 alkyl groups, diols having the structure HO-R 4 -- OH, and polyglycols having the structure HO-R 3 -(-O-R 4 -)n-OH; wherein each R 3 and R 4 is the same or different and selected from the group consisting of CI-C 6 straight or branched chain alkyl groups; and wherein m and n are each in a range of 1 to 100.
[43] 43. The photostabilized photoactive composition of claim 42, comprising a diester of formula (III) wherein Ri and R 2 are 2-ethylhexyl.
[44] 44. The photostabilized photoactive composition of claim 1, wherein said mixture includes a cosmetically acceptable carrier.
[45] 45. The photostabilized photoactive composition of claim 1, wherein said mixture includes an oil phase having a dielectric constant of at least about 8.
[46] 46. A method of increasing the UV absorbing life of a composition containing (a) a dibenzoylmethane derivative and (b) a cinnamate ester comprising adding a compound of formula (I) in an amount effective to prevent the reaction of (a) with (b); or to photostabilize (a) and/or (b). - 55 - WO 2009/020676 PCT/US2008/058458
[47] 47. The photostabilized photoactive composition of claim 1, wherein the photoactive compound is a water-soluble UV-absorbing compound.
[48] 48. The photostabilized photoactive composition of claim 47, wherein the phoactiev compound is a sulfonated UV-absorbing compound.
[49] 49. The photostabilized photoactive composition of claim 48, wherein the sulfonated UV absorbing compound is selected from the group consisting of phenylene- 1,4 bis(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid and its corresponding salts, 2-phenylbenzimidazole-5-sulfonic acid and its corresponding salts, and mixtures thereof.
[50] 50. The photostabilized photoactive composition of claim 1, wherein the photoactive compound is a hydroxybenzophenone of the following structural formula: where R I and R 2 independent of one another are hydrogen, Ci-C 20 -alkyl, C 3 -Cio-cycloalkyl or C 3 -CIo-cyloalkenyl, wherein the substituents R and R 2 together with the nitrogen atom to which they are bound can form a 5- or 6-ring, and R 3 is a C 1 -C 20 - alkyl radical.
[51] 51. The photostabilized photoactive composition of claim 50, futher including at least one dialkyl naphthalate comprising the structural formula: where R 1 and R2 are independently one of branched and unbranched alkyl groups with 6 to 24 carbons atoms. - 56 - WO 2009/020676 PCT/US2008/058458
[52] 52. The photostabilized photoactive composition according to claim 50, comprising at least one further UVA filter substance and/or a broadband filter comprising at least one of dibenzoylmethane derivatives and 2,4-bis{ [4-(2-ethylhexyloxy)-2 hydroxyiplenyl }-6-(4-methoxyphenyl)- 1,3,5-triazine.
[53] 53. The photostabilized photoactive composition according to claim 50, further comprising at least one UV filter substance selected from the group consisting of UV-A filters, UV-B filters, broad-band filters, triazines, benzotriazoles, organic pigments, inorganic pigments, and mixtures thereof.
[54] 54. The photostabilized photoactive composition of claim 1, wherein the photoactive compound comprises a benzotriazole compound that has the structure R, Ro where RI and R 2 are, independently of one another, selected from the group consisting of branched and unbranched: (a) Ci-Ci 8 -alkyl radicals; (b) C 5 -C 12 -cycloalkyl or aryl radicals; wherein said R 1 and R2 are optionally substituted by one or more Ci-C 4 -alkyl groups.
[55] 55. The photostabilized photoactive of claim 54, wherein the benzotriazole UV filter compound has the structure - 57 - WO 2009/020676 PCT/US2008/058458
[56] 56. The photostabilized photoactive of claim 54, wherein the benzotriazole compound has the structure
[57] 57. A method of solubilizing or stabilizing a benzotriazole compound which comprises adding a solubilizing or stabilizing effective amount of one or more alkoxycrylene of formula I: R 1 COOR 3 (I) R2 C =N wherein at least one of Ri and R 2 is a straight or branched chain CI-C 30 alkoxy radical, and any non-alkoxy R 1 or R 2 is hydrogen; and R 3 is a straight or branched chain C -C 30 alkyl radical.
[58] 58. The photostabilized photoactive composition of claim 1, wherein the photoactive compound is a particulate UV absorbing substance. - 58 - WO 2009/020676 PCT/US2008/058458
[59] 59. The photostabilized photoactive composition of claim 58, wherein at least one particulate UV filter substance is micronized inorganic pigment.
[60] 60. The photostabilized photoactive composition as claimed in claim 59, wherein the micronized inorganic pigment is a micronized metal oxide.
[61] 61. The photostabilized photoactive composition as claimed in claim 60, wherein the micronized metal oxide is an oxide of a metal selected from the group consisting of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium, and mixtures thereof.
[62] 62. The photostabilized photoactive composition as claimed in claim 60, wherein the micronized metal oxide further comprises barium sulfate.
[63] 63. The photostabilized photoactive composition as claimed in claim 60, wherein the micronized metal oxide has a primary particle size of less than 300 nm.
[64] 64. The photostabilized photoactive composition as claimed in claim 63, wherein the micronized metal oxide has a primary particle size of 10 to 150 nm.
[65] 65. The photostabilized photoactive composition as claimed in claim 60, wherein the micronized metal oxide is a surface treated metal oxide.
[66] 66. The photostabilized photoactive composition as claimed in claim 1, wherein the particulate UV absorbing substance is present in an amount of 0.01 to 20 weight % based on the total weight of the composition.
[67] 67. The photostabilized photoactive composition as claimed in claim 54, further comprising at least one additional UV filter substance selected from the group consisting of triazines, benzotriazoles, organic, inorganic pigments, and mixtures thereof.
[68] 68. The photostabilized photoactive composition as claimed in claim 54, further comprising at least one UV-A filter substance or broad-band filter substance. - 59 - WO 2009/020676 PCT/US2008/058458
[69] 69. The photostabilized photoactive composition of claim 68, wherein said at least one UV-A filter substance or broad-band filter substance includes at least one dibenzoylmethane derivative.
[70] 70. The photostabilized photoactive composition of Claim 69, wherein the dibenzoylmethane derivative is selected from the group consisting of 4-(tert-butyl)-4' methoxydibenzoylmethane,2,4-bis {[4-(2-ethylhexyloxy)-2-hydroxylphenyl} -6-(4 methoxyphenyl)- 1,3, 5-triazine, and mixtures thereof.
[71] 71. The photostabilized photoactive composition of claim 1, wherein the photoactive compound comprises: (a) an asymmetrically substituted triazine UV filter compound; and (b) one or more dialkyl naphthalates having the structural formula wherein R I and R 2 are, independently of one another, branched or unbranched alkyl groups having 6 to 24 carbon atoms.
[72] 72. The composition of claim 1, wherein the dialkyl naphthalate is diethylhexyl naphthalate.
[73] 73. The composition of claim 71, wherein the asymmetrically substituted triazine compound is selected from the group consisting of: 2,4-bis { [4-(2-ethylhexyloxy)-2-hydroxylphenyI -6-(4-methoxyphenyl)- 1,3,5-triazine; 2,4-bis { [4-(3-sulfonato-2-hydroxypropyloxy)-2-hydroxy]phenyl } -6-(4 methoxyphenyl)-1,3,5-triazine sodium salt; 2,4-bis { [4-(3-(2-propyloxy)-2-hydroxypropyloxy)-2-hydroxylphenyl} -6-(4 methoxyphenyl)- 1,3,5-triazine; 2,4-bis { [4-(2-ethylhexyloxy)-2-hydroxy]phenyl 1-6- [(4-2 -methoxyethoxycarbonyl) phenylamino]- 1,3,5-triazine; - 60 - WO 2009/020676 PCT/US2008/058458 2,4-bis { [4-(3-(2-propyloxy)-2-hydroxypropyloxy)-2-hydroxyphenyl} -6-[(4 ethoxycarbonyl)phenylamino I- 1,3,5-triazine; 2,4-bis { [4-(2-ethylhexyloxy)-2-hydroxy]phenyl} -6-(1 -methylpyrrol-2-yl)- 1,3, 5 triazine; 2,4-bis {[4-tris(trimethylsiloxysilylpropyloxy)-2-hydroxyI phenyl }-6-(4 methoxyphenyl)- 1,3,5-triazine; 2,4-bis{ I [4-(2-methylpropenyloxy)-2-hydroxyl]phenyl} -6-(4-methoxyphenyl)- 1,3,5 triazine; 2,4-bis{[4-(1', 1', 1',3',5',5',5'-heptamethylsiloxy-2-methylpropyloxy)-2 hydroxyiphenyl }-6-(4-methoxyphenyl)- 1,3,5-triazine; and dioctylbutylamidotriazone.
[74] 74. A method of solubilizing or stabilizing an asymmetrically substituted triazine compound which comprises of adding a solubilizing or stabilizing effective amount of an alkokycylene of formula I: R / COOR 3 (1) R2 C=N wherein at least one of R, and R 2 is a straight or branched chain C 1 -C 30 alkoxy radical, and any non-alkoxy R 1 or R 2 is hydrogen; and R 3 is a straight or branched chain C-C 30 alkyl radical.
[75] 75. The photostabilized photoactive composition of claim 1, wherein the composition includes an oxidation-sensitive or UV-sensitive ingredient selected from the group consisting of coenzyme Q1O, vitamin A and derivatives thereof, vitamin E and derivatives thereof, lipoic acid and derivatives thereof and carotenoids.
[76] 76. The photostabilized photoactive composition as claimed in claim 75, wherein the at least one oxidation-sensitive or UV-sensitive active ingredient includes vitamin E or derivatives thereof. - 61 - WO 2009/020676 PCT/US2008/058458
[77] 77. The photostabilized photoactive composition as claimed in claim 1, further comprising at least one UV filter substance selected from the group consisting of triazines, benzotriazoles, UV filters liquid at room temperature, organic pigments and inorganic pigments.
[78] 78. The photostabilized photoactive composition as claimed in claim 1, further comprising at least one UV-A filter substance or broadband filter selected from the group consisting of 2,4-bis{ [4-(2-ethylhexyloxy)-2-hydroxylphenyl}-6-(4-methoxy- phenyl)-1,3,5 triazine, phenylene-1,4-bis(2-benzimidazyl)-3,3'-5,5'-tetras-ulfonic acid bis-sodium salt, benzene- 1,4-di(2-oxo-3-bornylidenemethyl- 10--sulfonic acid, 2-(2H-benzotriazol-2-yl)-4 methyl-6-[2-methyl-3-[1,3,3,3-te-trameth- yl-l [(trimethylsilyl)oxy]disiloxanyl propyl ]phenol, and mixtures thereof.
[79] 79. A method of accepting electronic singlet state excited energy from a photon excited photoactive compound, by absorbing singlet excited state energy from, and thereby photostabilizing said photoactive compound, comprising mixing said photoactive compound with a compound of formula (1): R1 C COOR 3 (1), R2 C C=N wherein one or both of R I and R 2 is a straight or branched chain C -C 12 alkoxy radical, and R 3 is a straight or branched chain CI-C 24 alkyl radical, and exposing the mixture to UV radiation in an amount sufficient for the photoactive compound to reach an electronic singlet excited state, whereby the compound of formula (I) accepts the singlet excited state energy from the excited photoactive compound, thereby returning the photoactive compound to its ground state so that it is capable of absorbing additional UV radiation.
[80] 80. The method of claim 79, wherein R, is methoxy and R 2 is hydrogen.
[81] 81. The method of claim 79, wherein R 2 is methoxy and Ri is hydrogen.
[82] 82. The method of claim 81, wherein R 3 is a C 6 -C 24 straight chain or branched alkyl. - 62 - WO 2009/020676 PCT/US2008/058458
[83] 83. The method of claim 79, wherein the compound of formula (I) is present in an amount in the weight range of 0.1% to 20%, based on the total weight of the composition.
[84] 84. The method of claim 83, wherein the compound of formula (I) is present in an amount in the weight range of 0.1% to 10%, based on the total weight of the composition.
[85] 85. The method of claim 84, wherein the compound of formula (I) is present in an amount in the weight range of 0.1% to 5%, based on the total weight of the composition.
[86] 86. The method of claim 79, wherein the molar ratio of the compound of formula (I) to the photoactive compound is less than 0.8.
[87] 87. The method of claim 86, wherein the molar ratio of the compound of formula (1) to the photoactive compound is about 0.1 to about 0.6.
[88] 88. The method of claim 84, wherein the compound of formula (I) is present in an amount in the weight range of 3% to 8%, based on the total weight of the composition.
[89] 89. The method of claim 79, wherein the photoactive compound is selected from the group consisting of p-aminobenzoic acid and salts and derivatives thereof; anthranilate and derivatives thereof; dibenzoylmethane and derivatives thereof; salicylate and derivatives thereof; cinnamic acid and derivatives thereof; dihydroxycinnamic acid and derivatives thereof; camphor and salts and derivatives thereof; trihydroxycinnamic acid and derivatives thereof; dibenzalacetone naptholsulfonate and salts and derivatives thereof; bebzalacetophenone naphtholsulfonate and salts and derivatives thereof; dihydroxy-naphthoic acid and salts thereof; o-hydroxydiphenyldisulfonate and salts and derivatives thereof; p hydroxdydiphenyldisulfonate and salts and derivatives thereof; coumarin and derivatives thereof; diazole derivatives; quinine derivatives and salts thereof; quinoline derivatives; hydroxyl-substituted benzophenone derivatives; methoxy-substituted benzophenone derivatives; uric acid derivatives; vilouric acid derivatives; tannic acid and derivatives thereof; hydroquinone; benzophenone derivatives; 1, 3, 5- triazine derivatives; phenyldibenzimidazole tetrasulfolnate and salts and derivatives thereof; terephthalyidene dicamphor sulfonic acid and salts and derivatives thereof; methylene bis-benzotriazolyl - 63 - WO 2009/020676 PCT/US2008/058458 tetramethylbutylphenol and salts and derivatives thereof; bis-ethylhexyloxyphenol methoxyphenyl triazine and salts and derivatives thereof; and combinations of the foregoing.
[90] 90. The method of claim 79, wherein the photoactive compound comprises a dibenzoylmethane derivative.
[91] 91. The method of claim 89, wherein the photoactive compound comprises a dibenzoylmethane derivative selected from the group consisting of 2 methyldibenzoylmethane; 4- methyldibenzoylmethane; 4-isopropyldibenzoylmethane; 4-tert butyldibenzoylmethane; 2,4-dimethydibenzoylmethane; 2-5- dimethydibenzoylmethane; 4,4 diispropyldibenzoylmethane; 4,4-dimethoxydibenzoylmethane; 4-tert-butyl-4 methoxdibenzoylmethane; 2-methyl-5-isopropy-4-methoxydibenzoylmethane; 2-methyl-5 tert-butyl-4-methoxydibenzoylmethane; 2,4-dimethyl-4-methoxydibenzoymethane; 2,6 dimethyl-4-tert-butyl-4-methoxydibenzolmthane, and combinations thereof.
[92] 92. The method of claim 79, wherein the photoactive compound comprises a combination of a derivative of cinnamic acid and a dibenzoylmethane derivative.
[93] 93. The method of claim 92, wherein the derivative of cinnamic acid comprises 2 ethylhexyl-p-methoxycinnamate.
[94] 94. The method of claim 79, further comprising a diester or polyester of naphthalene dicarboxylic acid selected from the group consisting of compounds of formula (II) and (III), and combinations thereof: HO -R 3 -0 2 C - CO 2 -- R 4 -OH (II) I >j _ R10 2 C - C02 -R 4 -CO2- - CO 2 -- R2 (111) - 64 - WO 2009/020676 PCT/US2008/058458 wherein Ri and R 2 are the same or different and selected from the group consisting of CI-C 22 alkyl groups, diols having the structure HO-R 4 -OH, and polyglycols having the structure HO-R 3 -(-O-R4-)n-OH; wherein each R 3 and R 4 is the same or different and selected from the group consisting of CI-C 6 straight or branched chain alkyl groups; and wherein m and n are each in a range of 1 to 100.
[95] 95. The method of claim 94, comprising a diester of formula (III) wherein RI and R2 are 2-ethylhexane.
[96] 96. The method of claim 79, wherein said mixture includes a cosmetically acceptable carrier.
[97] 97. The method of claim 79, wherein said mixture includes an oil phase having a dielectric constant of at least about 8.
[98] 98. A photostabilized photoactive composition comprising a mixture of a photoactive compound and a compound of formula (V): (V) 0M N O N A 0 R O Rs/1-B (R7 2Y 0 ((R )b wherein A and B are the same or different and are selected from the group consisting of oxygen, amino and sulfur; R1 and R 3 are the same or different and are selected from the group consisting of CI-C 30 alkyl, C 2 -C 3 0 alkylene, C 2 -C 30 alkyne, C 3 -C 8 cycloalkyl, CI-C 30 substituted alkylene, C 2 -C 30 substituted alkyne, aryl, substituted aryl, heteroaryl, heterocycloalkyl, substituted heteroaryl and substituted heterocycloalkyl; R 2 is selected from the group consisting of C 1 -C 30 alkyl, C 2 -C 30 alkylene, C 2 C 30 alkyne, C 3 -C 8 cycloalkyl, CI-C 30 substituted alkyl, C 3 -C 8 substituted cycloalkyl, CI-C 30 substituted alkylene, C 2 -C 30 substituted alkyne; R 4, R , R6 and R7 are the same or different and are selected from the group consisting - 65 - WO 2009/020676 PCT/US2008/058458 of CI-C 30 alkoxy straight chin on branched and a, b, c and d are each either 0 or 1, and a, b, c and d add up to 1, 2, 3, or 4.
[99] 99. The composition of claim 98, wherein the photoactive compound is selected from a dibenzoylmethane derivative, a cinnamate ester, and a combination thereof.
[100] 100. The composition of claim 99, wherein the photoactive compound comprises octyl salicylate.
[101] 101. A method of accepting electronic singlet state excited energy from a photon excited photoactive compound, thereby photostabilizing said photoactive compound, comprising mixing said photoactive compound with a compound of formula (VI): (VI) N O N R 2 1 2 A0 R O R3 B(R a R--(R 00 (R(R)a R 4) ,(R ) c wherein A and B are the same or different and are selected from the group consisting of oxygen, amino and sulfur; RI and R 3 are the same or different and are selected from the group consisting of CI-C 30 alkyl, C 2 -C 30 alkylene, C 2 -C 3 0 alkyne, C 3 -C 8 cycloalkyl, C 1 -C 30 substituted alkylene, C 2 -C 30 substituted alkyne, aryl, substituted aryl, heteroaryl, heterocycloalkyl, substituted heteroaryl and substituted heterocycloalkyl; R 2 is selected from the group consisting of C 1 -C 30 alkyl, C 2 -C 30 alkylene, C 2 C 3 o alkyne, C 3 -Cs cycloalkyl, C 1 C 30 substituted alkyl, C 3 -C 8 substituted cycloalkyl, C-C 3 0 substituted alkylene, C 2 -C 30 substituted 4 5 6 7 alkyne; R , R , R and R 7 are the same or different and are selected from the group consisting of C -C 30 alkoxy straight chin on branched and a, b, c and d are each either 0 or 1, and a, b, c and d add up to 1, 2, 3, or 4 and exposing the mixture to UV radiation in an amount sufficient for the photoactive compound to reach an electronic singlet excited state, whereby the compound of formula (V) accepts the singlet excited state energy from the excited - 66 - WO 2009/020676 PCT/US2008/058458 photoactive compound, thereby returning the photoactive compound to its ground state so that it is capable of absorbing additional UV radiation. - 67 -

类似技术:

---

公开号 | 公开日 | 专利标题

---

AU2008284217B2|2012-11-08|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions

---

US9125829B2|2015-09-08|Method of photostabilizing UV absorbers, particularly dibenzyolmethane derivatives, e.g., Avobenzone, with cyano-containing fused tricyclic compounds

---

US8133477B2|2012-03-13|Dispersions of inorganic particulates containing alkoxycrylene

---

US8263051B2|2012-09-11|Photostabilization of resveratrol with alkoxycrylene compounds

---

US7713519B2|2010-05-11|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions

---

US20040166072A1|2004-08-26|Photostabilization of a sunscreen composition with a combination of an alpha-cyano-beta, beta-diphenylacrylate compound and a dialkyl naphithamate

---

US8278332B2|2012-10-02|Photostabilization of retinoids with alkoxycrylene compounds

---

EP2022779B1|2011-05-25|Alkoxy Polyester Compounds, Compositions and Methods of Use Thereof

---

AU2017202533B2|2019-04-04|Compositions, apparatus, systems, and methods for resolving electronic excited states

---

US20090074684A1|2009-03-19|Use of alpha olefin copolymers as photostabilizing agents in sunscreen compositions

同族专利:

---

公开号 | 公开日

---

EP2025324B1|2013-08-14|

---

US20090291141A1|2009-11-26|

---

US7959834B2|2011-06-14|

---

US8263050B2|2012-09-11|

---

BRPI0815103A2|2014-09-30|

---

US20100283015A1|2010-11-11|

---

JP2010535779A|2010-11-25|

---

US8075808B2|2011-12-13|

---

US20090291055A1|2009-11-26|

---

EP2025324A1|2009-02-18|

---

US20090208435A1|2009-08-20|

---

AU2008284217B2|2012-11-08|

---

US20090041847A1|2009-02-12|

---

US20090246157A1|2009-10-01|

---

US20090291054A1|2009-11-26|

---

WO2009020676A1|2009-02-12|

---

US7588702B2|2009-09-15|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

US429542A||1890-06-03||Corset |

---

US2623060A|1949-11-04|1952-12-23|Sharp & Dohme Inc|Alkylidenecyanoacetates and improved process for preparation thereof|

---

DE1222926C2|1960-03-09|1976-07-15|General Aniline & Filme Corporation, New York, N.Y. |PROTECT ORGANIC SUBSTANCES AGAINST UV RADIATION|

---

BE601113A|1960-03-09||||

---

US3215724A|1961-09-18|1965-11-02|Gen Aniline & Film Corp|alpha-cyano-beta, beta-diphenyl acrylic acid esters|

---

FR2350095B1|1976-05-03|1982-10-01|Oreal||

---

DE2816819A1|1978-04-18|1979-10-31|Bayer Ag|LIGHT PROTECTION AGENTS|

---

US4396240A|1978-06-16|1983-08-02|Henson Artel R|Storage system|

---

US4307240A|1980-05-30|1981-12-22|General Electric Company|Alkoxysilanes and method for making|

---

US4562278A|1984-10-12|1985-12-31|Dow Corning, Ltd.|Organosilicon compounds and preparation and use thereof|

---

US4617374A|1985-02-15|1986-10-14|Eastman Kodak Company|UV-absorbing condensation polymeric compositions and products therefrom|

---

SU1273360A1|1985-05-21|1986-11-30|Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова|Alpha-furfurylidene-alpha-cyanoacetates as inhibitors of radical polymerization of unsaturated compounds in storage|

---

US4707537A|1986-09-30|1987-11-17|Eastman Kodak Company|UV-absorbing condensation polymeric compositions and products therefrom|

---

FR2658075B1|1990-02-14|1992-05-07|Oreal|PHOTOSTABLE FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A BETA, BETA-DIPHENYLACRYLATE OR ALPHA-CYANO-BETA, BETA-DIPHENYLACRYLATE.|

---

IT1255729B|1992-05-19|1995-11-15|Giuseppe Raspanti|s-triazine derivatives as photostabilising agents|

---

US5393862A|1993-08-09|1995-02-28|Eastman Chemical Company|Naphthalenedicarboxylic acid containing polymer compositions having reduced fluorescence|

---

US5663213A|1994-02-28|1997-09-02|Rohm And Haas Company|Method of improving ultraviolet radiation absorption of a composition|

---

EP0711803B1|1994-11-08|2000-01-19|Teijin Limited|Method for preventing emission of fluorescence from polyalkylenenaphthalene-2,6-dicarboxylate|

---

JP3423827B2|1994-12-09|2003-07-07|帝人株式会社|Method for preventing fluorescence of polyethylene naphthalate molded article|

---

US5783307A|1996-11-04|1998-07-21|Eastman Chemical Company|UV stabilized multi-layer structures with detectable UV protective layers and a method of detection|

---

US5738842A|1996-11-29|1998-04-14|3V Inc.|Sun protecting cosmetic compositions comprising derivatives of dibenzoylmethane, of diphenylcyanoacrylic acid and of triazine|

---

US6117973A|1997-02-24|2000-09-12|Georgia Tech Research Corp.|PNA monomers with electron donor or acceptor|

---

US6001952A|1997-06-18|1999-12-14|Eastman Chemical Company|Polyester containing benzylidene having reduced fluorescence|

---

CA2241645A1|1997-07-14|1999-01-14|F. Hoffmann-La Roche Ag|Light-screening agents|

---

US5989528A|1998-07-30|1999-11-23|The Procter & Gamble Company|Sunscreen compositions|

---

FR2785540B1|1998-11-10|2002-09-20|Oreal|PROCESS FOR THE PHOTOSTABILIZATION OF SOLAR FILTERS DERIVED FROM 1,3,5-TRIAZINE|

---

US7064114B2|1999-03-19|2006-06-20|Parker Hughes Institute|Gel-microemulsion formulations|

---

US6113931A|1999-03-25|2000-09-05|The C.P. Hall Company|Clear formulations containing diesters or polyesters of naphthalene dicarboxylic acid|

---

US5993789A|1999-03-25|1999-11-30|The C.P. Hall Company|Photostable sunscreen compositions containing dibenzoylmethane derivative, E.G., parsol® 1789, and diesters or polyesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor |

---

DE10058290A1|2000-11-23|2002-05-29|Basf Ag|Process for stabilizing polyolefins|

---

US20020127192A1|2001-01-04|2002-09-12|John Murphy|Lipstick with translucent or transparent region|

---

US6905525B2|2001-04-02|2005-06-14|Ciba Specialty Chemicals Corporation|Candle wax stabilized with piperazinones|

---

US6551605B2|2001-04-06|2003-04-22|Haarmann & Reimer|Diesters or polyesters of naphthalene dicarboxylic acid as solubilizer/stabilizer for retinoids|

---

DE10117336A1|2001-04-06|2002-10-10|Max Planck Gesellschaft|Novel light protection and skin care products through stabilized light protection components and reduction of damaging photo products|

---

US6518451B2|2001-04-26|2003-02-11|Haarmann & Reimer|Diesters of naphthalene dicarboxylic acid|

---

DE10141474A1|2001-08-29|2003-03-20|Beiersdorf Ag|Stabilization of UV-sensitive active ingredients|

---

DE10162840A1|2001-12-20|2003-07-03|Beiersdorf Ag|Cosmetic and dermatological light protection formulations containing water-soluble UV filter substances and benzoxazole derivatives|

---

JP4152732B2|2001-12-27|2008-09-17|株式会社トクヤマ|Resin composition|

---

US6537529B1|2002-03-05|2003-03-25|The C.P. Hall Company|Sunscreen compositions and methods and materials for producing the same|

---

US6485713B1|2002-03-05|2002-11-26|The C. P. Hall Company|Sunscreen compositions and methods and materials for producing the same|

---

US20040047817A1|2002-09-06|2004-03-11|Bonda Craig A.|Photostabilization of a sunscreen composition with low levels of an alpha-cyano-beta,beta-diphenylacrylate compound|

---

US6899866B2|2002-09-06|2005-05-31|Cph Innovations Corporation|Photostabilization of a sunscreen composition with a combination of an α-cyano-β, β-diphenylacrylate compound and a dialkyl naphithalate|

---

US6890521B2|2002-09-06|2005-05-10|The C.P. Hall Company|Photostabilization of a sunscreen composition with low levels of an α-cyano-β, β-diphenylacrylate|

---

US6800274B2|2002-09-17|2004-10-05|The C.P. Hall Company|Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition|

---

US6919473B2|2002-09-17|2005-07-19|Cph Innovations Corporation|Photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition|

---

DE10333675A1|2003-07-24|2005-03-03|Aventis Pharma Deutschland Gmbh|Perfusion method for the production of erythropoietin|

---

US7292156B2|2003-10-07|2007-11-06|Underground Solutions Technologies Group, Inc.|Remote tapping method and system for internally tapping a conduit|

---

JP2005139263A|2003-11-05|2005-06-02|Fuji Photo Film Co Ltd|Cellulose solution, cellulose film, polarizer, and liquid crystal display device|

---

US7534420B2|2004-02-25|2009-05-19|Hallstar Innovations Corp.|Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostablizing properties, compositions containing same, and methods of using the same|

---

US7235587B2|2004-07-01|2007-06-26|Cph Innovations Corporation|Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same|

---

AT396704T|2004-07-02|2008-06-15|Johnson & Johnson Consumer Fr|SILICONE-MODIFIED PROTEIN CONTAINING SUN PROTECTION PREPARATION|

---

ES2426750T3|2005-02-18|2013-10-25|American Dye Source, Inc.|Method for coding materials with a luminescent label and apparatus for reading the same|

---

KR101256248B1|2005-03-23|2013-04-18|디에스엠 아이피 어셋츠 비.브이.|Polysiloxane coated metal oxide particles|

---

US8158678B2|2005-04-07|2012-04-17|Cph Innovations Corp.|Photoabsorbing, highly conjugated compounds of cyanoacrylic esters, sunscreen compositions and methods of use|

---

US20080286217A1|2007-05-14|2008-11-20|Chaudhuri Ratan K|Sunscreen compositions and methods|

---

ES2634638T3|2007-08-07|2017-09-28|Symrise Ag|Use of troxerutin to deactivate fluorescence of disodium phenyldibenzimidazole tetrasulfonate|

---

US7597825B2|2007-08-09|2009-10-06|Hallstar Innovations Corp.|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions|

---

US7754191B2|2007-08-09|2010-07-13|Hallstar Innovations Corp.|Method of quenching electronic excitation of chromophore-containing organic molecules photoactive compositions|US7597825B2|2007-08-09|2009-10-06|Hallstar Innovations Corp.|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions|

---

US8133477B2|2007-08-09|2012-03-13|Hallstar Innovations Corp.|Dispersions of inorganic particulates containing alkoxycrylene|

---

US8263051B2|2007-08-09|2012-09-11|Hallstar Innovations Corp.|Photostabilization of resveratrol with alkoxycrylene compounds|

---

US7754191B2|2007-08-09|2010-07-13|Hallstar Innovations Corp.|Method of quenching electronic excitation of chromophore-containing organic molecules photoactive compositions|

---

US8070989B2|2007-08-09|2011-12-06|Hallstar Innovations Corp.|Photostabilization of retinoids with alkoxycrylene compounds|

---

US8329148B1|2007-08-09|2012-12-11|Hallstar Innovations Corp.|Photostabilization of coenzyme Q compounds with alkoxycrylene compounds|

---

US8431112B2|2007-08-09|2013-04-30|Hallstar Innocations Corp.|Photostabilization of cholecalciferol with alkoxycrylene compounds|

---

US8257687B2|2007-08-09|2012-09-04|Hallstar Innovations Corp.|Photostabilization of coenzyme Q compounds with alkoxycrylene compounds|

---

US7964245B2|2008-06-27|2011-06-21|Hallstar Innovations Corp.|UV-absorbing and photostabilizing polymers|

---

US8314154B2|2008-09-22|2012-11-20|Louise Holyfield|Topical skin care formulations|

---

EP2201927A3|2008-12-29|2013-05-22|Henkel AG & Co. KGaA|Sun screen compounds|

---

US20120189665A1|2009-05-04|2012-07-26|Milanka Susak|Cosmetic Compositions Comprising Cyanodiphenylacrylates And Film Forming Polmers|

---

US8765156B2|2009-05-04|2014-07-01|Elc Management Llc|Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound|

---

US20120201766A1|2009-05-04|2012-08-09|Milanka Susak|Topical Compositions Comprising An Alkoxylated Diphenylacrylate Compound And An Organic Nonionic Emulsifier|

---

US9095543B2|2009-05-04|2015-08-04|Elc Management Llc|Cosmetic compositions comprising cyanodiphenylacrylates|

---

EP2427181A4|2009-05-08|2012-10-03|Elc Man Llc|Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester|

---

US8206691B2|2009-11-04|2012-06-26|Conopco, Inc.|Sunscreen composition with fatty acid alkanolamides|

---

US8173108B2|2009-11-04|2012-05-08|Conopco, Inc.|Sunscreen composition|

---

KR101753655B1|2010-11-22|2017-07-06|아모레퍼시픽|Composition for sunscreen|

---

KR101767206B1|2010-11-22|2017-08-14|아모레퍼시픽|Composition for screening light|

---

WO2012130606A1|2011-03-29|2012-10-04|Unilever Nv|A sunscreen composition|

---

CA2830288C|2011-03-29|2019-01-22|Unilever Plc|A sunscreen composition|

---

AU2012245305B2|2011-04-21|2016-09-22|Edgewell Personal Care Brands, Llc|Synergistic UVR absorbing adjuvant combination|

---

US9005588B2|2011-12-22|2015-04-14|Mary Kay Inc.|Substantive sunscreen formulation|

---

US8795640B2|2011-12-22|2014-08-05|Mary Kay Inc.|Lip formulation|

---

DE102012205526A1|2012-04-04|2013-10-10|Beiersdorf Ag|Stable cosmetic preparation with high pigment content|

---

US9145383B2|2012-08-10|2015-09-29|Hallstar Innovations Corp.|Compositions, apparatus, systems, and methods for resolving electronic excited states|

---

WO2014026151A1|2012-08-10|2014-02-13|Hallstar Innovations Corp.|Compositions, apparatus, systems, and methods for resolving electronic excited states|

---

WO2014025370A1|2012-08-10|2014-02-13|Hallstar Innovations Corp.|Tricyclic energy quencher compounds for reducing singlet oxygen generation|

---

US9125829B2|2012-08-17|2015-09-08|Hallstar Innovations Corp.|Method of photostabilizing UV absorbers, particularly dibenzyolmethane derivatives, e.g., Avobenzone, with cyano-containing fused tricyclic compounds|

---

US20170189294A1|2013-04-01|2017-07-06|Eveready Battery Company, Inc.|Non-Irritating, Non-Whitening Photoprotective Compositions|

---

CA2918905A1|2013-07-22|2015-01-29|The Procter & Gamble Company|Uv compositions having low active concentrations and high in vivo spf|

---

ES2819207T3|2014-04-29|2021-04-15|Symrise Ag|Active mixes|

---

KR20210138673A|2019-03-15|2021-11-19|바스프 에스이|Sunscreen composition comprising butyl methoxydibenzoylmethane, a triazine derivative and a light stabilizer|

---

WO2021180839A1|2020-03-13|2021-09-16|Basf Se|Anti-aging care composition comprising perfumes|

法律状态:
2013-03-07| FGA| Letters patent sealed or granted (standard patent)|

---

2017-10-26| MK14| Patent ceased section 143(a) (annual fees not paid) or expired|

优先权:

---

申请号 | 申请日 | 专利标题

---

US11/891,281||2007-08-09||

---

US11/891,281|US7597825B2|2007-08-09|2007-08-09|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions|

---

US12/022,758||2008-01-30||

---

US12/022,758|US7588702B2|2007-08-09|2008-01-30|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions|

---

PCT/US2008/058458|WO2009020676A1|2007-08-09|2008-03-27|Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions|

---